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Abstract 
The insulin signalling pathway provides a conserved mechanism used by 
metazoan animals to regulate growth, metabolism, and behaviour in response to 
environmental cues. The FOXO transcription factors regulate cellular function in the 
presence of low levels of insulin signalling. This thesis describes the identification ofthe 
Drosophila melanogaster homologue ofFOXO (dFOXO), that has high sequence 
conservation in the forkhead box DNA binding domain and Akt phosphorylation sites, 
when compared to analogous genes in mice, humans, and Caenorhabiditis elegans. 
Overexpression of dFOXO in the developing eye leads to a characteristic phenotype 
resulting from growth reduction. This phenotype can be rescued by co-expression of 
upstream PI3K signalling components, unless FOXO is mutated to be non-responsive to 
Akt phosphorylation. Ubiquitous expression of dFOXO at different stages of larval 
development closely replicates the effects of starvation, and endogenous dFOXO activity 
is modulated by the presence of nutrients. These results suggest that dFOXO is important 
for the response of Drosophila larvae to starvation. Analysis of dFOXO loss of function 
suggests that dFOXO is required for the adaptation of young larvae to starvation, but is 
not required during starvation in the later stages of larval development. A role for 
dFOXO in larval wandering is suggested by the observations that loss of dFOXO leads to 
reduced height of pupation, overexpression of dFOXO induces wandering, and 
endogenous dFOXO activity is increased during the wandering stage of the larval life 
cycle. In summary, dFOXO may regulate growth, behaviour, and starvation resistance in 
response to reduced PI3K signalling in Drosophila. 
ii 
Studies in Chapter 1.2 utilize the UAS/Gal4 ectopic expression system. We have 
shown that Gal4 causes a rough eye phenotype in adult flies when expressed at high 
levels during eye development. The rough eye phenotype is characterized by a loss of 
ommatidia! organization and is accompanied by a high level of apoptosis in the eye 
imaginal discs where Gal4 is expressed. These phenotypes are essentially eliminated 
through co-expression of the caspase inhibitor, p35. This suggests that Gal4 has the 
capability to act as a toxic protein that activates the cellular apoptotic machinery. These 
results should be taken into consideration in the design and analysis of any experiment 
involving the use of the UAS/Gal4 system. 
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Chapter 1 
Identification and regulation of the FOXO family of 
transcription factors in Drosophila: implications in the 
developmental response to starvation 
Chapter 1.1: Introduction and Overview 
2 
1.1.1- Signal Transduction in Metazoans 
Life on earth is remarkably diverse, yet amazingly simple. An estimated 1.7 
million species have been described and it is possible that there are anywhere between 
two and ten million species living on the planet. The majority of these species are rarely 
seen by humans because of their small size or remote location, but we have only to look 
around ourselves to witness the great array of plants, animals, and insects inhabiting the 
earth. Despite the great diversity of organisms there is a high level of conservation in the 
fundamental cellular processes that define life. DNA replication, transcription, 
translation, membrane transport, protein structure, nucleic acid structure, and many 
metabolic pathways are cellular features that are shared among all life forms and are 
thought to have evolved about 3.2 billion years ago in the eubacteria [1]. Even the 
common traits that define eukaryotic cells probably evolved about 2 billion years ago in 
prokaryotes and the early single celled eukaryotes. These traits include the formation of 
cilia and flagella, the existence of membrane bound organelles, the ability to perform 
endo- and exocytosis, the processes of mitosis and meiosis, the dynamic formation of an 
actin/tubulin cytoskeleton, the CDK/cyclin mechanism for the control of cell cycle, and 
the formation of histone/DNA complexes [1]. Indeed, it is amazing to see such diversity 
in organisms that have evolved using what seems like a limited set of core cellular 
processes. 
During metazoan development, cellular processes such as growth, metabolism, 
proliferation, survival, and differentiation, are controlled by a diverse array of signalling 
molecules [2-8]. The first evidence that such molecules existed came from experiments 
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using the amphibian embryo in the early 1900s. In 1924, Spemann and Mangold 
generated a two-headed salamander by transplanting a small piece of tissue from one 
embryo to another [9]. As the cells surrounding the transplanted tissue would normally 
not have developed into a second head, the transplanted cells must have communicated 
with adjacent cells to directly influence their development. During eighty years, the 
following progress has been made in identifying the mechanisms by which cell signalling 
occurs. 
Genetic and biochemical studies have revealed a general mechanism for cell 
signalling that is conserved among metazoan animals. Usually a signalling molecule, the 
ligand, activates a transmembrane receptor by binding to the extracellular domain and 
inducing phosphorylation of an intracellular domain [2-8]. This leads to the activation of 
kinases that phosphorylate each other sequentially resulting in the activation or repression 
of effector molecules [2-8]. Surprisingly there are only seven main signalling pathways 
known to control the development of metazoan animals [7]. These include the TGF-~ 
pathway [5], the Wnt pathway [2], the Hedgehog (Hh) pathway [4], the receptor tyrosine 
kinase (RTK) pathway [8], the Notch/Delta pathway [6], the JAK/STAT pathway [3], 
and the nuclear receptor pathway [1 0]. All of these pathways conform to the generalized 
scheme of signal transduction with the exception of the nuclear receptor pathway, in 
which the ligands cross the cell membrane and bind to nuclear receptors inside the cell 
[1 0]. All of the different signalling pathways show amazing flexibility and can be used in 
various combinations during development to perform different functions in different 
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situations. As a result, a limited set of signalling mechanisms can direct all aspects of 
development, leading to the formation of many different cells, tissues, and body types. 
The importance of the core signalling pathways in the regulation of cellular 
processes is highlighted by the prevalence of human diseases that are caused by 
disruption of signalling genes [I1-20]. Many human cancers can be linked to defects in 
components of one or more signalling cascades [II, 12, I4, 15, IS, 19]. In these cases, 
disruption of normal signalling can lead to deregulation of growth and the formation of 
tumours. Neurodegenerative diseases can also result from disruption of signalling genes 
that normally promote neuronal survival or direct neuronal development [I3, 16, I9, 20]. 
Additionally, insulin resistance in diabetic individuals may result from disruption of 
signaling genes regulating nutrient homeostasis [I9, 20]. Thus, medical science can 
benefit greatly from 'basic' research that contributes to the understanding of the 
components and mechanisms controlling cell signalling networks. The conservation of 
signalling pathways in vertebrates and invertebrates has allowed the use of model 
organisms such as Drosophila melanogaster and Caenorhaebditis elegans to elucidate 
the components ofthe different pathways and the developmental contexts in which they 
occur [1, 7, 21]. To extend this work, mammalian cell culture studies have elucidated 
many of the biochemical mechanisms through which these signalling pathways operate 
[2-8]. These combined efforts are beginning to reveal a complex picture, in which 
signalling events elicit a response that is dependent on cell type, developmental stage, 
signal strength, and interactions with other signalling cascades. The advent of molecular 
techniques has rapidly increased the progress made in understanding these processes, but 
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we are still a long way from having a true understanding of how cells interpret the 
constant barrage of signals that they receive. 
Model organisms provide an excellent system to determine the physiological 
importance of signal transduction genes. Chapters 1.2 and 1.3 of this thesis describe the 
analysis of the Drosophila homologue of the forkhead box subgroup '0' (FOXO) family 
of transcription factors. FOXO transcription factors are inhibited by PBK/Akt signalling 
that is conserved in nematodes, mammals, and flies [22, 23]. Previous to this work, the 
mechanisms ofPBK/Akt signalling had been described in mammals, C. elegans, and in 
part, in Drosophila [24-26]. This thesis describes the identification ofthe solitary FOXO 
family member in Drosophila and an analysis of its regulation by upstream signalling 
components and nutrients [27, 28]. This work is the first published study to examine a 
FOXO transcription factor in Drosophila, and provides evidence of an evolutionarily 
conserved role for these transcription factors in the adaptive response of metazoan 
animals to fluctuations in nutrient availability [27, 28]. Subsequent sections of the 
introduction will provide background information on liS signalling and a review of the 
literature describing the function and regulation of the FOXO family of transcription 
factors. 
1.1.2- The liS pathway: ligands, receptors, and adaptors 
The liS pathway has emerged as an important regulator of growth in response to 
developmental signals and nutrients (Figure 1) [21, 29, 30]. The main activators of liS 
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signalling in mammals are insulin, IGF1, and IGF2. Insulin is produced in the pancreatic 
~-cells in response to circulating nutrients [31] and I GF -1/2 are produced primarily in the 
liver in response to growth factors and nutritional cues [30, 32]. The insulin receptor 
(InR) and the IGF receptor (IGFR) belong to the receptor tyrosine kinase (RTK) family 
of transmembrane receptors [33-35]. These receptors are composed of two extracellular 
a-subunits and two intracellular ~-subunits that are linked together by disulfide bridges. 
The a-subunit is responsible for ligand binding while the ~-subunit signals to 
intracellular signalling molecules through it tyrosine kinase domain [35]. InR and IGFR 
belong to the class II family ofRTKs that contain cysteine-rich motifs in the a-subunit 
that are impm1ant for ligand binding [36, 3 7]. Binding of a ligand to the extracellular 
domain of the RTK initiates the tyrosine kinase activity of the intracellular domain, and 
autophosphorylation ofthe ~-subunit at several tyrosine residues [36, 37]. Tyrosine 
phosphorylation of the P-subunit creates binding sites for proteins that have 
phosphotyrosine binding (PTB) domains (Figure 1). The first of these to be discovered, 
the insulin receptor substrate 1 (IRS I), was identified by immunoprecipitation using 
phosphotyrosine antibodies against cell extracts from insulin-stimulated cells [38]. These 
antibodies revealed a 185 kDa protein belonging to a family ofiRS proteins that contain 
several characteristic domains, including a PTB domain, a PH (pleckstrin homology) 
domain, and SH-2 binding domains [21, 36, 37]. The SH-2 binding domain provides a 
link between InR/IGFR and two downstream pathways, the Ras/MAPK pathway, and the 
phosphoinositide 3-kinase (PI3K) pathway. The Ras/MAPK pathway is a highly 
conserved signalling mechanism that is used in eukaryotes from yeast to mammals [39]. 
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Both Ras and Pl3K are activated by binding to IRS though their SH2 binding domains 
(Figure 1). The remainder of this discussion will focus on the components ofthe liS 
system that function downstream ofPI3K. 
1.1.3 -Intracellular signal transduction in response to liS activation: PI3K and Akt 
Pl3K phosphorylates phosphoinositide residues at the 3' hydroxyl group of the 
inositol ring, converting phosphotidylinositide 4,5-bisphosphate (PIP2) to 
phosphotidylinositide 3,4,5,-triphosphate (PIP3). There are three classes ofPI3K 
proteins, of which class I is the major isoform that is activated by insulin [ 40]. Class I 
PBK exists as a heterodimer with an 85 kDa (p85) adaptor subunit and a 110 kDa (p 11 0) 
catalytic subunit. In mammals, there are four isoforms of p 110, each encoded by a 
different gene, and seven versions of p85 that are generated by alternative splicing of 
three different genes [ 40, 41]. The adaptor subunit binds to phosphotyrosine residues in 
IRS proteins through its SH2 domain, leading to the recruitment of the 110 kDa catalytic 
subunit (Figure 1 ). Once bound to IRS, PBK becomes activated and is able to catalyse 
the formation ofPIP3 on the inner surface of the plasma membrane (Figure 1) [40, 41]. 
The lipid phosphatase, PTEN (phosphatase and tensin homologue), can negatively 
regulate Pl3K signalling through the dephosphorylation ofPIP3 . PTEN is classified as a 
tumour suppressor because of its negative effect on cell growth and because mutations in 
the human PTEN gene have been linked to a variety of tumours [42]. Thus, PI3K and 
PTEN act in opposition to each other to control cell function. 
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The generation ofPIP3 is critical for the activation of signalling components 
downstream ofPI3K [40]. PIP3 residues recruit signalling molecules to the plasma 
membrane by binding to proteins with PH domains [40]. Two of the major PH-domain-
containing proteins that are influenced by the presence ofPIP3 are Akt (also known as 
protein kinase B) and phosphoinositide-dependent kinase- I (PDKI) (Figure I) [24, 40, 
41]. Akt is a serine/threonine kinase that is recruited to the membrane and 
phosphorylated in response to the generation ofPIP3 [24, 41, 43]. Although the 
mechanism of Akt activation is not well understood, at least one of the phosphorylation 
events is mediated by PDKI [24, 41]. There are three homologues of Akt in mammals 
that can elicit their effect by altering enzyme activity directly, or through modulation of 
downstream signalling pathways and transcription factors. Akt is phosphorylated after 
insulin stimulation and relocates from the membrane, to the cytoplasm and the nucleus, 
where it phosphorylates multiple proteins involved in the regulation of cell survival, 
metabolism, cell cycle, transcription, and translation (Figure I) [24, 41, 43, 44]. The 
minimum motif required for Akt to recognize its substrate is Arg-Xaa-Arg-Yaa-Zaa-
Ser/Thr-Hyd, where Xaa is any amino acid, Yaa and Zaa are usually small residues other 
than glycine, and Hyd is a bulky hydrophobic residue such as phenylalanine or leucine 
[45]. The first Akt substrate to be identified was glycogen synthase kinase 3~ (GSK3~), 
a kinase that phosphorylates and inhibits glycogen synthase (GS). Phosphorylation by 
Akt inhibits GSK3~, leading toGS activation and possibly to the increased storage of 
sugars as glycogen in response to insulin [41, 43, 46]. Other Akt targets include, the cell 
death genes, BAD (Bcl-2 antagonist causing cell death) and caspase 9, the cell cycle 
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inhibitor, p21, TOR and the FOXO family of transcription factors [24. 41, 43, 44]. 
Phosphorylation of these targets by Akt may have effects on cell survival and/or cell 
proliferation. 
The proliferation and growth of cells requires a high capacity for protein 
synthesis. Akt can influence the cellular capacity to make proteins by modulating the 
TOR (target ofrapamycin) pathway (Figure 1). TOR is an evolutionarily conserved 
nutrient sensing kinase that phosphorylates ribosomal S6 kinase (S6K) and eukaryotic 
initiation factor 4E (eiF-4E) binding protein (4E-BP) [47, 48]. TOR-mediated 
phosphorylation activates S6K activity [47, 48]. S6 may be involved in promoting 
translation ofmRNAs containing a 5' terminal oligopyrimidine tract (TOP), which often 
encode for components ofthe translational apparatus [ 49]. TOR mediated 
phosphorylation of 4E-BP leads to its dissociation from eiF-4E [48]. 4E-BP binding 
inhibits elF -4E, which is pm1 of a ribosome binding complex that promotes translation 
through interaction with the 7-methyl-guanosine cap ofmRNA [50]. Thus, TOR activity 
leads to increased ribosome biosynthesis and the selective increase in translation of 
proteins making up the translational apparatus [47, 48, 51]. 
Akt modulates TOR activity through TSC 1 and 2 (tuberous sclerosis complex 1 
and 2) (Figure 1) [21, 47, 52, 53]. These two proteins exist in a complex that can bind to 
the small GTPase Rheb, to turn on its GTPase activity. Rheb is a member of the Ras 
family of GTP-binding proteins and activation of its GTPase activity leads to the 
conversion ofRheb-GTP to Rheb-GDP [52]. Rheb-GDP is inactive, whereas Rheb-GTP 
is active and can promote TOR kinase activity. Akt prevents activation ofRheb GTPase 
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activity through phosphorylation ofTSC2, leading to the dissociation of the TSC1/2 
complex [21, 47, 52, 53]. Thus, Akt regulates the translational capacity ofthe cell 
through modulation ofTSC/Rheb/TOR signalling. 
Often, cell signalling events cause major changes in cellular activities that are 
mediated by alterations in gene transcription. Akt can alter the transcriptional profile of 
the cell through two main mechanisms, activation of nuclear factor-KB (NF-KB) and 
inhibition ofFOXO (Figure 1 ). NF-KB promotes transcription of genes involved in cell 
survival. Although the physiological significance is still unsure, Akt may relieve the 
repression ofNF-KB by its cytosolic inhibitor, IKB (inhibitor ofNF-KB) [24, 41]. IKB 
binds to NF-KB in the cytoplasm, preventing it from entering the nucleus and activating 
gene transcription. IKB is targeted for degradation after phosphorylation by IKK (IKB 
kinase). Akt has been shown to activate IKK, suggesting that Akt, via IKK, can promote 
cell survival by activation ofNF-KB-mediated transcription. Alternatively, Akt may 
effect cellular processes through inhibition of gene transcription. Akt-mediated 
inhibition of the FOXO transcription factors is well documented [22] and is believed to 
be one of the critical consequences of Akt activation. The following sections will 
provide a detailed review ofthe biochemical regulation of the FOXO transcription 
factors. 
1.1.4 -Discovery of the FOXO transcription factors in human cancer 
The FOXO proteins belong to a family of transcription factors that contain a 
highly conserved 100 amino acid forkhead box DNA binding domain made up ofthree 
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a-helices separated by two large loops. Members ofthe human FOXO family were 
identified as genes disrupted through chromosomal translocations seen in patients with 
alveolar rhabdomyosarcoma [54, 55] and acute lymphocytic leukemia [56-59]. The 
forkhead in rhabdomyosarcoma (FKHR) gene was found as a fusion oftwo genes, FKHR 
with either PAX3 [55] or PAX7 [54], in patients with rhabdomyosarcoma. The resultant 
fusion proteins contain the entire PAX3/7 DNA binding, domain fused to the 
transactivation domain ofFKHR (Figure 2). These fusion proteins displays PAX-like 
DNA binding, with aberrant regulation ofPAX target genes, and the ability to induce the 
transformation of cultured cells [60]. However, a PAX3/FKHR fusion protein did not 
cause tumour formation in mice, leading to the hypothesis that disruption of the FKHR 
gene is an important factor contributing to cellular transformation [61]. Two other 
human FOXO homologues, FKHR-like 1 (FKHRL 1) and acute lymphocytic Jeukemia-1-
fused-gene-from-chromosome X (AFX), were identified in chromosomal translocations 
resulting in fusion to the mixed lineage leukemia (MLL) gene [58, 59]. These chimeras 
contain the forkhead transactivation domain, fused to the DNA binding domain ofMLL. 
The FOXO transactivation domain was necessary for cellular transformation [62, 63], 
thus, it appears that disruption of normal FOXO activity is an important step in the 
progression of certain types of cancer. 
The identification of the FOXO transcription factors in human cancer Jed to 
increased interest in these proteins. Additional homologues have since been identified in 
mice, chicks, zebrafish [64], nematodes [65], fruit flies [27, 66, 67], and rats [68]. A 
unified nomenclature was devised for the forkhead/winged helix genes in which FOX 
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transcription factors. See text for details. 
(forkhead box) is the abbreviated name for the entire family, with sub-groups that are 
defined by the letters A to 0 [69]. Thus, FKHR, FKHRLl, and AFX, were renamed to 
FOXOl, FOX03a, and FOX04, respectively [69]. Although the precise role ofthese 
transcription factors in cancer is still largely undefined, research within the last six years 
has resulted in greater understanding of the function ofthe FOXO family members and 
the factors that regulate their activity. 
1.1.5- Regulation ofFOXO through nuclear shuttling, proteasomal degradation, 
and proteolytic cleavage 
The first evidence showing that FOXO factors are regulated by insulin signalling 
came from genetic studies examining dauer larvae formation in C. elegans. Dauer larvae 
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arise as a developmental adaptation to nutritional stress or crowding [70]. Mutations in 
daf2, an insulin receptor homologue, and age-l, a homologue ofthe Pl3K catalytic 
subunit, lead to arrested development in the dauer larvae stage. Mutations in the C. 
elegans FOXO homologue, dafl6, negate the effects of daf2 and age-l mutations [65], 
suggesting that the main purpose of daf-2/age-1 signalling is to antagonize daf-16. These 
results led biochemists to test this possibility in mammalian cells. Indeed, it was shown 
that activation ofPBK/Akt signalling leads to phosphorylation ofFOXO and causes it to 
be sequestered in the cytoplasm, while inhibition ofPBK/Akt signalling leads to 
dephosphorylation and increased nuclear localization ofFOXO (Figure 1) [71-78]. Three 
Akt phosphorylation sites were identified that are conserved in all of the FOXO family 
members. These sites include a threonine residue near theN-terminus (Tl ), and two 
serine residues, one in the DNA binding (S 1) domain, and one just outside the C-terminal 
side of the DNA binding domain (S2) (Figure 2) [71-78]. Preventing the phosphorylation 
of these sites by mutating them to alanine residues renders FOXO proteins resistant to 
cytoplasmic translocation in response to Akt activation [71, 75, 77, 78]. Serum and 
glucocorticoid-regulated kinase (SGK) is a closely related kinase that can also 
phosphorylate the Tl, Sl, and S2 sites in response to liS (Figure 2). However, while Akt 
shows a preference for phosphorylation of the Sl site, SGK preferentially phosphorylates 
the S2 site [79]. The physiological significance of these preferences is unclear, yet it is 
possible that these two kinases act in redundant or parallel pathways. 
Regulation of nuclear shuttling is one ofthe main controls over FOXO activity 
[22, 80]. Shuttling ofFOXO is regulated by a nuclear localization sequence (NLS) in the 
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DNA binding domain and a nuclear export sequence (NES) in the transactivation domain 
(Figure 2). Nuclear export ofFOXO is dependent on several components ofthe nuclear 
export machinery including Crm 1 and the small GTPase, Ran [71, 81, 82]. These factors 
are thought to mediate nuclear export ofFOXO by binding to the NES (Figure 1 and 2). 
Studies that examined point mutations in the phosphorylation sites ofFOXO have 
revealed an intricate mechanism that regulates the paradoxical activities of the NLS and 
NES motifs [22, 68]. The NLS ofFOXO may be disrupted upon phosphorylation of the 
S 1 site, as this residue is located within the NLS, and addition of a negative charge at this 
site by substituting a glutamate residue leads to inhibition of nuclear import [81]. 
Mutation ofthe Sl site to alanine prevents phosphorylation ofTl and S2, thus the Sl site 
acts as a gate-keeper for the phosphorylation of the other residues [75, 83]. 
Phosphorylation ofTl and Sl may also promote export from the nucleus and the 
cytoplasmic accumulation ofFOXO by providing a consensus sequence for binding to 
14-3-3 proteins [72, 84] (Figure 2). Binding of 14-3-3 at these residues increases the rate 
ofCrml/Ran mediated nuclear export and inhibits the potential for nuclear import by 
antagonizing the NLS [84]. Phosphorylation of the S2 site is also important in promoting 
the nuclear export ofFOXO proteins, by providing a consensus sequence for the 
phosphorylation of an additional site, S3, by casein kinase 1 (CK1) [82]. In turn, 
phosphorylation ofthe S3 site provides a primer for CK }-mediated phosphorylation of 
another serine residue, S4. S2, S3, and S4 are immediately adjacent to each other and to 
an additional phosphorylation site, S5 (Figure 2). S5 is constitutively phosphorylated by 
the dual specificity kinase, DYRK1A, reducing FOXO-mediated gene transactivation 
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[85]. Disruption of the stretch of adjacent phosphorylation sites from S2-S5 does not 
affect binding to Crm 1 or Ran, but does inhibit nuclear export [82]. This stretch of 
phosphorylated serine residues may provide a 'patch' of negatively charged amino acid 
side chains that is necessary for nuclear export [82]. In summary, S 1 phosphorylation 
allows subsequent phosphorylation events that act to fine tune the nuclear shuttling of 
FOXO. 
Additional phosphorylation ofFOXO occurs via the small GTPase, RaJ, and its 
downstream effector, JNK (jun N-tetminal kinase) (Figures 1 and 2). Ral!JNK signalling 
is activated by multiple factors, including oxidative stress and cytokines. FOX04 has 
been shown to undergo RaJ-dependent phosphorylation at two threonine residues near the 
C-terminus ofthe protein, T2 and T3 (Figure 2) [86, 87]. Phosphorylation ofT2 and T3 
is mediated by JNK, which is activated through RaJ in response to oxidative stress and 
cytokines [88]. Phosphorylation at these sites is required to achieve the full effect of 
FOX04 on gene transactivation [86, 88]. Ral!JNK signalling may provide an liS-
independent mechanism ofFOXO activation that occurs in response to oxidative stress. 
However, these RaJ-dependent phosphorylation sites are not conserved in all FOXO 
family members, suggesting a role specific to the function ofFOX04. 
In addition to nuclear shuttling, PBK/Akt signalling can modulate FOXO activity 
by regulating the stability of the protein in the cell. This occurs through two independent 
mechanisms; (1) targeting FOXO to the ubiquitin proteasome system [89, 90], and (2) 
proteolytic cleavage (Figure 1) [91, 92]. Phosphorylation ofFOXO increases the 
ubiquitination ofFOXO and reduces FOXO levels in a proteasome-dependent manner 
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[89, 90]. Proteasomal degradation ofFOXO is dependent on Akt phosphorylation and 
cytoplasmic localization [89]. This provides an additional mechanism for 
downregulation ofFOXO after nuclear export. In contrast, the proteolytic cleavage of 
FOXO may provide a mechanism of inhibition that does not depend upon nuclear export 
[91, 92]. FOXO proteins that are constitutively nuclear due to a nuclear export-disabling 
mutation in the NES can still be inhibited [93]. Both FOX01 and FOX03a have been 
shown to undergo proteolytic cleavage mediated by caspase-3-like proteases (Figure 1) 
[91, 92]. This cleavage results in the release of a large N-terminal fragment (532 amino 
acids for FOXO 1) that is transcriptionally inactive [91, 92] and may act to inhibit gene 
transactivation by the full length FOXO [92]. Indeed, the regulation ofFOXO activity is 
very complex and involves many cellular processes, including nuclear shuttling, 
phosphorylation, ubiquitination, protein-protein interactions, and proteolytic cleavage. 
1.1.6- Targets of FOXO and regulation of transcription through interactions with 
co-activators 
The regulation ofFOXO gene transactivation is as complex as the regulation of 
FOXO localization in the cell. FOXO proteins can activate the transcription of many 
genes involved in the regulation of apoptosis [72, 94, 95], cell cycle arrest [22], 
metabolism [96], and stress resistance [97-1 00] (Figure 1 ). Activation of gene 
transcription by FOXO occurs when FOXO binds to DNA at a consensus sequence called 
the FOXO recognition element (FRE). Recent research suggests that the effect ofFOXO 
on target gene expression is also influenced by interactions with transcriptional co-
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activators, nuclear receptors, acetylases, and deacetylases [22, 68, 80, 101]. Thus, a 
myriad of factors are able to influence the activity and specificity ofFOXO-mediated 
gene transactivation. 
The FOXO proteins can influence the fate of many different cell types. FOXO 
induces apoptosis in cultured blood cells and neurons. In lymphocytes, FOXO has been 
shown to cause apoptosis in the absence of cytokines by activating transcription of BIM 
(Bcl-2 interacting mediator of cell death), and the Fas ligand (FasL) [72, 94]. In cultured 
sympathetic neurons, FOXO causes cell death in the absence ofNGF (nerve growth 
factor), through transcription ofBIM [95]. Many other cell types, such as fibroblasts, 
undergo cell cycle arrest in response to FOXO expression. FOXO promotes G 1 arrest in 
these cells by activating expression of p27KIPI [86, 102-1 07] and, possibly, by promoting 
the stability ofp27KIPI through a post-translational mechanism [1 07]. FOXO 
homologues have also been implicated in the expression of p 130, a promoter of cell 
senescence [98], and cyclin G2, which accumulates during G0 and inhibits cell cycle 
entry [1 08]. In addition, FOX03a can promote G2 cell cycle arrest through transcription 
ofGADD45 in response to oxidative stress [99, 100]. FOXO also may inhibit the cell 
cycle by down-regulation of the expression of cyclins D1 and D2, both being required for 
cell cycle progression [1 09, 11 0]. The ability ofFOXO to down-regulate transcription 
appears to be independent ofFRE binding [109], suggesting that FOXO acts as a 
transcriptional corepressor through protein-protein interactions with other transcription 
factors. 
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In mammals, insulin levels decline in response to decreased blood glucose, and 
the body shifts from synthesis to mobilization of energy storage molecules, such as 
glycogen and triglycerides. In addition, gluconeogenesis is increased in the liver in order 
to provide the brain with an essential source of carbohydrates. When circulating insulin 
levels decline, the FOXO homologues may affect metabolism in various tissues and 
organs [96]. FOXO proteins can activate the expression of several gluconeogenic 
enzymes including, G6Pase (glucose-6-phosphatase) [111, 112], G6Pase transporter 
[113], PEPCK (phosphoenolpyruvate carboxykinase) [111, 114, 115], and PGC-1a [116] 
(Figure 1 ). FOXO-mediated expression of these genes may promote gluconeogenesis in 
the liver during periods when insulin production is decreased [96]. In muscle cells, 
FOXO can promote the expression ofPDK4 (pyruvate dehydrogenase kinase 4) [117] in 
order to maintain glucose levels during starvation. FOXO can also promote the 
utilization of fat stores in muscle cells of starving animals through expression of genes 
involved in fatty acid metabolism, such as LPL (lipoprotein lipase) [118], and AdipoRl/2 
[119]. Finally, FOXO may prevent the formation of fat cells through expression of p21, 
an inhibitor of adipocyte differentiation [120]. These findings suggest that FOXO acts in 
a tissue specific manner to regulate metabolism during periods of decreased blood insulin 
in mammals. 
Genetic studies in C. elegans [121] and Drosophila [66] have implicated the 
FOXO transcription factors in the cellular response to oxidative stress. In mammalian 
cells, FOXO proteins appear to be activated in response to oxidative stress and can 
influence the transcription of several stress resistance genes (Figure 1) [97-1 00]. The 
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growth arrest and DNA damage-response gene (GADD45) is induced by FOXO in 
response to oxidative stress and mediates FOXO-induced G2 arrest and DNA repair [99, 
1 00]. G2 arrest in response to stress may allow more time for DNA repair after damage 
has incurred prior to mitosis. FOXO may also provide protection from reactive oxygen 
species (ROS) by promoting expression of manganese superoxide dismutase (MnSOD) 
[98] to detoxifY oxygen free radicals, and sterol carrier protein (SCP2) to protect fatty 
acids from peroxidation [97]. As a result, FOXO may promote the long term survival of 
cells by increasing their resistance to oxidative stress and DNA damage. 
FOXO-mediated gene transcription is regulated through protein-protein 
interactions with multiple cofactors [122-124]. The presence or absence ofthese 
cofactors in certain cell types may influence the tissue specific pattern ofFOXO-
mediated gene expression. FOXO interacts with p300/CBP (CREB binding protein) to 
mediate the effect of glucocorticoids on the expression of the IGFBP1 gene [124]. 
FOXO also mediates the effects of glucocorticoids on G6Pase and PEPCK transcription, 
through interaction with PGC-1 a (peroxisome proliferator-activated receptor co-activator 
a) in the liver [123]. Thus, by binding to coactivators, FOXO can integrate signals from 
multiple circulating factors, including glucocorticoids and insulin (Figure 1 ). FOXO can 
also interact with the co factors, DYRK I A/B, to promote G6Pase expression in a manner 
that is independent ofDYRK1A/B kinase activity [122]. In addition, FOXO may 
regulate endometrial differentiation through transcriptional coactivation of CEBP~ 
(CAAT-enhancer binding protein~) [125]. These studies show the diversity ofthe 
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FOXO transcription factors in their ability to control cell function through protein-protein 
interactions. 
Another mechanism responsible for the regulation ofFOXO-mediated gene 
transcription occurs through interactions with nuclear receptors. Nuclear receptors are 
signalling molecules that bind to their ligands inside the cell, leading to receptor 
dimerization and subsequent regulation of gene transcription [1 0]. FOXO homologues 
may bind to nuclear receptors through a conserved LxxLL motif located near the C-
terminus of the protein (Figure 2). FOXO family members have been shown to interact 
with the oestrogen receptor (ER) [126, 127], the progesterone receptor (PR) [127], the 
thyroid hormone receptor (TR) [127], the glucocorticoid receptor (GR) [127], the retinoic 
acid receptor (RAR) [127], the androgen receptor (AR) [128], the peroxisome proliferator 
activated receptor y (PPARy) [129], and hepatic nuclear factor 4 (HNF4) [130]. 
Interactions with these receptors and the resulting effects on transcription are variable, 
depending on the specific receptor involved. For example, binding to ER is ligand-
dependent, whereas binding to RAR is ligand-independent [127]. Interactions between 
FOXO and ER have been shown to augment ER-mediated transcription and inhibit 
FOXO-mediated transcription [126]. However, FOXO has also been shown to repress 
ER-mediated transcription [127], reflecting differences in cell type or target promoter 
sequences. FOXO acts to repress HNF4-mediated transcription in the absence of insulin, 
yet HNF4 seems to have no effect on FOXO mediated transcription [130]. In contrast, 
PPARy and FOXO show mutual repression oftranscriptional activity [129]. Clearly, the 
interaction ofFOXO family members with nuclear receptors has specific effects on 
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transcription, which may result in the fine tuning of gene expression profiles in 
physiological systems. 
Additional regulation ofFOXO gene transactivation occurs through interactions 
with acetylases and deacetylases. The cofactor, p300/CBP, interacts directly with FOXO 
and promotes its acetylation at several sites [124, 131, 132], while SIRTl (silent 
information regulator oftranscription 1) interacts with FOXO and causes its 
deacetylation [23, 133-135] (Figure 1). Acetylation by p300/CBP inhibits FOXO-
mediated transactivation ofp27KIPI expression [131]. To oppose this, SIRTl 
d I . . . . f 27KIPI d h . eacety atwn causes an mcrease m expressiOn o p an t e stress res1stance genes 
GADD45 and MnSOD [23, 133, 134]. SIRTl deacetylation can also decrease expression 
of the pro-apoptotic protein BIM [133, 135] and can disrupt the ability of dFOXO to 
induce apoptosis [135]. Oxidative stress is required for the interaction ofFOXO with 
SIRTl, suggesting that SIRTl deacetylase activity acts to promote cell cycle arrest and 
inhibit apoptosis in cells that are undergoing oxidative stress [22, 23; 80, 101]. 
1.1.7- Physiological function of the FOXO transcription factors: insights from 
model organisms 
Biochemical analysis of the liS pathway and the FOXO transcription factors has 
revealed many potential functions for this signalling cascade [22, 80]. Analysis ofFOXO 
target genes and coactivators has suggested a role for these transcription factors in the 
regulation of apoptosis, cell cycle, metabolism, and stress resistance [22, 80]. However, 
it is difficult to determine the physiological or developmental significance of these 
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findings within the context of cultured cells. Studies in model organisms, such as C. 
elegans, mice, and Drosophila are providing insights into the physiological functions of 
the FOXO family members. Consistently, analysis ofthe FOXO homologues in whole 
organisms reveals that these transcription factors are critical regulators of stress 
resistance, longevity, and glucose metabolism in the absence of liS activity. 
Caenorhaebditis elegans 
The FOXO transcription factors were first placed downstream of insulin 
signalling by analysis of mutants regulating dauer formation in C. elegans [65, 136, 137]. 
The dauer larvae forms as a developmental response to starvation or crowding that is 
characterized by arrest of growth at a sexually immature stage along with altered 
metabolism to increase the storage of fat [70]. Mutations in the C. elegans homologues 
ofthe insulin receptor (daf-2) [65, 136-138], PBK (age-l, daf-23) [65, 136, 139], and 
Akt (aktl and akt2) [140] cause constitutive dauer formation and increased lifespan 
through a mechanism dependent on the activity ofthe FOXO homologue, daf-16 [65, 
136, 137, 140]. Mutations in insulin signalling components in C. elegans can also cause 
daf- I 6-dependent resistance to oxidative damage, UV stress, and hypertonic stress [25, 
121, 141]. In addition, forced activation of daf-16 in the nematode is sufficient to induce 
dauer formation [142], increased stress resistance [143], and increased longevity [143]. 
Exposure of C. elegans to starvation, heat, and oxidative stress causes a relocation of daf-
16 to the nucleus, and daf-2 and akt 1 and 2 are able to inhibit daf-16 nuclear localization 
in fed animals. Microarray analysis has demonstrated that daf-16 may promote increased 
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longevity and stress resistance by upregulating the expression of several groups of genes 
encoding stress resistance proteins, heat shock proteins, antimicrobial proteins, and 
metabolic enzymes [141, 144]. These studies suggest a global role for FOXO 
homologues in the response of C. elegans to environmental factors and in the protection 
of cells against stress. 
Mice (Mus musculus) 
Mutational analysis of FOXO homologues in mice has revealed the importance of 
these factors in diabetes and in mammalian development [120, 145-148]. Loss of 
function of FOXOJ in mice causes embryonic lethality due to multiple factors including 
impaired vascular development [148]. In contrast, mice lacking FOX03a and FOX04 
survive to adulthood with minimal defects [147, 148]. No noticeable abnormalities have 
been described for loss of FOX04 [148]. However, loss of FOX03a leads to age-
dependent infertility and abnormal follicular cell development [147, 148]. FOX03a may 
act to suppress follicle cell differentiation in the early stages of follicle growth [147]. 
Thus, in the absence of FOX03a, follicular activation occurs too early, leading to oocyte 
death and premature infertility [14 7]. 
Analysis of FOXOJ mutant heterozygous mice revealed that FOXOJ 
haploinsufficiency can rescue the diabetic phenotype observed in mice that are; 1) 
heterozygous for InR [146]; 2) homozygous for loss ofiRS [145]; and 3) fed a high fat 
diet (diet-induced diabetes) [120]. In addition, overexpression of activated FOXO in the 
liver or the pancreas is sufficient to induce a diabetic-like phenotype [146]. Thus, the 
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symptoms of diabetes result, in part, from the overactivation ofFOXO in selected tissues. 
The transcription of FOXOJ mRNA is increased in starved mice [117, 118, 149], and this 
increase is reversed when animals are re-fed [117, 149]. These experiments in mice show 
the importance ofthe FOXO homologues in mammalian development, and in the 
physiological response of adult mammals to reduced food intake. 
Drosophila melanogaster 
Like C. elegans, Drosophila has a single FOXO homologue (dFOXO) that 
regulates growth [27, 66, 67], stress resistance [66, 150], longevity [150-152], and the 
developmental response to starvation [27, 28]. Loss of the Drosophila insulin receptor 
substrate, chico, leads to the generation of adults that are reduced in size [153]. Analysis 
of flies with Joss of function mutations in dFOXO show that it is required for the 
reduction of growth observed in chico mutant flies [ 66]. In addition, overexpression of 
dFOXO can mediate growth reduction in the developing eye ofDrosophila [66, 67, 154]. 
These studies indicate that dFOXO is a negative regulator of growth, and in conjunction 
with evidence from mammalian cell culture, suggest that FOXO homologues act to 
inhibit cell cycle progression. 
Expression of dFOXO in the adult Drosophila fat body yields increased oxidative 
stress resistance [150] and lifespan [150, 151]. dFOXO has been shown to upregulate the 
expression of 4E-BP [66, 67], and Joss of function in either dFOXO or 4E-BP results in 
sensitivity to oxidative stress [66, 155]. Expression of 4E-BP in a dFOXO mutant 
background is sufficient to restore oxidative stress resistance [155]. In Drosophila, JNK 
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signalling also extends lifespan and increases stress resistance [152]. The increased 
lifespan observed upon increased JNK signalling is negated by heterozygosity for 
dFOXO [152]. These studies suggest that dFOXO mediates the effects of JNK signalling 
as well as loss of insulin signalling, and that 4E-BP is a critical downstream regulator of 
FOXO-induced resistance to oxidative stress. 
Analysis ofthe FOXO transcription factors in Drosophila has shed light upon 
their wider physiological importance. Chapters 1.2 [27] and 1.3 [28] tell a story that 
begins with the identification of dFOXO and ends by determining the role for dFOXO in 
the developmental adaptation of Drosophila larvae in response to nutritional stress. 
Chapter 1.2 describes dFOXO overexpression experiments that demonstrate interactions 
between dFOXO and upstream components of the PI3K/Akt signalling pathway. 
Additional overexpression studies show that dFOXO can mimic the effects of starvation 
on Drosophila larvae. Chapter 1.3 provides an analysis of the effects of starvation on 
endogenous dFOXO activity, and the effects of dFOXO loss of function during 
starvation. Evidence presented in chapter 1.3 supports a model where dFOXO is 
regulated by the presence of nutrients and is partly required for the developmental 
adaptation of Drosophila larvae to starvation. Evidence from chapters 1.2 and 1.3 
suggest an additional role for FOXO in the regulation of larval wandering behaviour. 
These studies provide a foundation, correlating physiological responses to dFOXO 
activity, with respect to control of growth, behaviour, and starvation response. 
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Chapter 1.2 
Expression of Drosophila FOXO regulates growth and can 
phenocopy starvation 
A version of this chapter is published as: 
Kramer, J.M., Davidge, J.T., Lockyer, J.M., and Staveley, B.E. (2003). Expression of 
Drosophila FOXO regulates growth and can phenocopy starvation. BMC Dev Biol3, 5. 
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1.2.1 - Abstract 
Background: Components ofthe insulin signalling pathway are important regulators of 
growth. The FOXO (forkhead box, sub-group "0") transcription factors regulate cellular 
processes under conditions oflow levels of insulin signalling. Studies in mammalian cell 
culture show that activation ofFOXO transcription factors causes cell death or cell cycle 
arrest. The Caenorhaebditis elegans homologue of FOXO, Daf-16, is required for the 
formation of dauer larvae in response to nutritional stress. In addition, FOXO factors 
have been implicated in stress resistance and longevity. 
Results: We have identified the Drosophila melanogaster homologue ofFOXO 
(dFOXO), which is conserved in amino acid sequence when compared to the mammalian 
FOXO homologues and Daf-16. Expression of dFOXO during early larval development 
causes inhibition of growth and alterations in feeding behavior. Inhibition of larval 
growth is reversible upon discontinuation of dFOXO expression. Expression of dFOXO 
during the third instar or at low levels during development leads to the generation of 
adults that are reduced in size. Analysis ofthe wings and eyes of these small flies 
indicates that the reduction in size is due to decreases in cell size and cell number. 
Overexpression of dFOXO in the developing eye leads to a characteristic phenotype with 
reductions in cell size and cell number. This phenotype can be rescued by co-expression 
of upstream insulin signalling components, dPI3K and dAkt, however, this rescue is not 
seen when FOXO is mutated to a constitutively active form. 
Conclusions: dFOXO is conserved in both sequence and regulatory mechanisms when 
compared with other FOXO homologues. The establishment of Drosophila as a model 
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for the study ofFOXO transcription factors should prove beneficial to determining the 
biological role of these signalling molecules. The alterations in larval development seen 
upon overexpression of dFOXO closely mimic the phenotypic effects of starvation, 
suggesting a role for dFOXO in the response to nutritional adversity. This work has 
implications in the understanding of cancer and insulin related disorders, such as diabetes 
and obesity. 
1.2.2 - Background 
The biological control of the size of an organism is one of the most elusive 
concepts in biology. What mechanisms determine the size differences between species? 
What genetic and environmental factors contribute to variations of size within a species? 
How does an individual regulate the size of its organs to maintain proportion with the rest 
of the body? Although much remains unanswered, it is clear that the size of an individual 
is directly related to the number of cells it has, and the size of these cells [1-3]. Thus, the 
final size of an organism is determined by the number of cell divisions that occur during 
development, and the amount of growth these cells undergo. When considering the size 
difference between two organisms, such as a mouse and a human, it is obvious that the 
main cause of the size difference is the total number of cells [2]. Intuitively, this may 
lead to the conclusion that the size of an organism is related to the rate of cell 
proliferation during development. However, experimental evidence shows that there are 
more subtle controls involved [4, 5]. For example, increasing or decreasing cell 
proliferation in the Drosophila imaginal discs does not alter the final size, but instead 
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produces discs with either an increased number of small cells or a decreased number of 
large cells [ 4, 5]. These studies indicate that there must be a genetically predetermined 
total cell mass and a mechanism for sensing this critical size. 
Studies in Drosophila demonstrate that the evolutionarily conserved insulin 
signalling pathway is involved in the control of body size, through alterations of cell size 
and cell number [1]. Seven Drosophila insulin-like peptides (diLPs) have been identified 
that are able to promote organism growth when expressed ubiquitously during 
development [6, 7]. The diLPs activate cell signalling through the Drosophila insulin 
receptor (dlnr), a receptor tyrosine kinase that can promote growth when overexpressed 
in the developing eye [6, 8]. Loss of function mutations in dlnr are lethal during 
embryogenesis [8]. However, reduction of dlnr levels through combination of weak 
heteroallelic mutations [9], or through partial loss of function mutations [6], reduces 
growth and leads to the development of small adults that have reduced cell size and 
number. In mammals, the insulin receptor promotes signalling through adaptor proteins, 
the insulin receptor substrates (IRS) 1-4, which are required to activate phosphoinositide-
3-kinase (PI3K) [1 0, 11]. PBK is a lipid kinase that phosphorylates inositide lipids on 
the inner surface of the cell membrane, leading to the activation of the serine/threonine 
kinase, Akt. Once activated, Akt phosphorylates many substrates that are involved in the 
regulation of metabolism, cell death/survival, and cell proliferation. Negative regulation 
of insulin signalling occurs through the tumor suppressor, phosphatase and tensin 
homolog (PTEN). PTEN removes phosphates from inositide lipids, thus acting in 
opposition to PI3K. This signalling mechanism appears to be conserved in Drosophila, 
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and the Drosophila homologues ofiRS 1-4 (chico), PBK (dP13K), Akt (dAkt) and PTEN 
(dPTEN) have all been individually implicated in the regulation of cell size, and cell 
number [ 1]. Flies that are homozygous for a null mutation in chico are smaller than 
normal due to a reduction in cell size and cell number [12]. Null mutations in dAkt are 
lethal [13], however, rescue of dAkt mutants through ectopic expression of dAkt during 
embryogenesis results in a small fly phenotype [14] similar to that seen with chico 
mutants and through reduction of dlnr activity. Clearly, components of the insulin 
signalling pathway act to control body and organ size through regulation of cell size and 
cell number during development. 
In addition to developmentally predetermined size control, many cells and 
organisms can alter their size according to environmental stimuli, such as nutrient 
limitation. When Drosophila larvae are raised under nutrient limited conditions the 
adults are smaller than well-fed flies [15, 16]. This phenomena appears to be 
phenocopied in the generation of small adults through inhibition of Drosophila insulin 
signalling [6, 9, 12, 14]. Interestingly, expression of dlLPs 3, 5, and 7 has been linked to 
the availability of nutrients [7]. These diLPs are produced in neurosecretory cells in the 
larval brain where they are released into the circulatory system [7]. These studies indicate 
that nutritional signals may regulate body size by modulating the circulating levels of 
diLPs 3, 5, and 7. 
Newly hatched Drosophila larvae require a nutritional signal to initiate the cell 
cycle in mitotic tissues [17]. Well-fed larvae increase their body mass very rapidly due to 
replication of cells in mitotic tissues. In contrast, larvae hatched into conditions of amino 
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acid starvation live in a state of developmental arrest for several days until nutrients 
become available to initiate the cell cycle [ 16, 17]. Dominant negative inhibition of 
dPI3K in developing Drosophila larvae has been shown to phenocopy the effects of 
amino acid starvation [18]. Expression of dPI3K in subsets of cells in the imaginal discs 
of starved larvae allows these cells to divide in the absence of nutritional signals [18]. 
Expression of dPI3K in the fat bodies of starved larvae significantly reduces their 
survival, thus conferring starvation sensitivity in these larvae [ 18]. This suggests that 
Drosophila insulin signalling may play a protective role in the response to starvation. 
An insulin-like signalling pathway involved in the response to nutrient limitation 
also exists in the nematode, Caenorhaebditis elegans. When C. elegans are raised under 
conditions of nutrient limitation, they enter an alternate developmental stage called the 
dauer larvae. The dauer stage is characterized by arrest of growth at a sexually immature 
stage along with altered metabolism to increase the storage of fat [19]. Mutations in 
components ofthe insulin signalling pathway in C. elegans lead to dauer larvae formation 
and increased life span [20-24]. A null mutation in the C. elegans gene, Daf-16, negates 
dauer formation and the life expanding effect of these mutations [21, 25, 26]. Thus, in C. 
elegans, Daf-16 is necessary for dauer formation and may be the primary mediator of cell 
function during low levels of insulin signalling. 
Daf-16 is the C. elegans homologue of a highly conserved group of Akt 
phosphorylatable forkhead transcription factors, the FOXO (forkhead box, subgroup "0") 
transcription factors. These transcription factors were first discovered as proto-
oncogenes, which were disrupted as a result of chromosomal translocations leading to 
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acute lymphocytic leukemia and rhabdomyosarcoma [27, 28]. Three versions ofFOXO 
have been identified in humans (FOXO 1, FOX03a, and FOX04; formerly known as 
FKHR, FKHR-L1, and AFX) and mice (Foxo1, Foxo3, and Foxo4), and additional 
homologues have been identified in zebrafish and chickens [29]. The FOXO 
transcription factors share a highly conserved forkhead box DNA binding domain in the 
N-terminal half of the protein, and three highly conserved Akt phosphorylation sites. 
Mammalian cell culture studies have shown that in the absence of Akt signalling, FOXO 
is able to activate gene transcription and cause cell death, cell cycle arrest, or cell 
senescence [30, 31]. In the presence of activated Akt, FOXO becomes phosphorylated 
and is sequestered in the cytoplasm through facilitation of 14-3-3 binding [32-35], and/or 
disruption of a nuclear localization signal [34, 36]. The down-regulation ofFOXO in this 
manner is, possibly, one of the most important consequences of Akt-mediated signalling. 
Based on evidence from studies in C. elegans and mammalian cell culture, it 
appears that FOXO transcription factors are a critical mediator of low levels of insulin 
signalling. To investigate this further, we have identified and characterized the 
Drosophila melanogaster version of FOXO. We show that Drosophila FOXO (dFOXO) 
retains the conserved domains seen in other organisms and is involved in the regulation 
of growth. Of special interest is that dFOXO appears to have an effect upon feeding 
behavior, and may be a key player in the response of Drosophila larvae to nutritional 
stress. 
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1.2.3 - Results 
dFOXO retains the functional domains found in Daf-16 and the mammalian FOXO 
homologues. 
The dFOXO gene consists of 10 exons and is spread out over approximately 31 kb 
in polytene chromosome section 88A within the genomic scaffolding region, A£003703, 
of the Berkeley Drosophila Genome Project (BDGP) (Figure 1A). dFOXO encodes a 
theoretical protein of 463 amino acids (Figure 1 B). Analysis of the complete Drosophila 
genome for additional dFOXO homologues revealed none. 
Alignment of dFOXO with the human homologues ofFOXO and Daf-16a1 using 
ClustalW [37] (Figure 1B) revealed that although the overall identity of amino acids is 
not high, the identity in the forkhead box DNA binding domain is between 74 and 86 
percent. The Akt phosphorylation sites are also well conserved in their relative position 
in the protein, and in sequence. The T1 site is located at T24 in dFOXO, the S1 site at 
S 160, and the S2 site at S239. These sites align with the human FOXO homologues in 
the ClustalW alignment, however the Daf-16 Sl, and S2 sites are slightly out of 
alignment (Figure 1B). All three of the potential Akt phosphorylation sites in dFOXO fit 
the Akt consensus target sequence (RxRxxS/T). 
Other notable features found in FOXO include a DYRK1A phosphorylation site, a 
14-3-3 binding site, a nuclear localization signal (NLS), a nuclear export signal (NES), 
and RaJ-dependent phosphorylation sites. A DYRK1A phosphorylation site was 
confirmed experimentally in FOX01 at S329 [38). This serine residue is conserved in 
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Figure 1: dFOXO encodes a protein that retains important functional domains found in other FOXO 
homologues. (A) Schematic representation of the dFOXO cDN A clone LD05 569 and its location in the 
genomic scaffolding, region AE003 703, of the BDG P sequence. (B) ClustalW alignment of the 
proposed dFOXO amino acid sequence with that of mammalian homologues (FOX01a, FOX03a, and 
FOX04) and Daf-16al. We have shown the alignment up to amino acid 284, for dFOXO, and to the 
corresponding amino acid in the alignment for the other homologues. Highlighted are: the T 1, S 1, and 
S2 Akt target sequences (yellow shading); the potential DYRK1 a/mnb phosphorylation site (arrow, and 
grey shading); and the forkhead box DNA binding domain (black box)."*" indicates nucleotides that are 
identical in all sequences in the alignment, ":" indicates conserved substitutions, according to the 
chemical nature of the amino acids, and"." indicates semi-conserved substitutions. Colors indicate the 
chemical nature of the amino acid; Red = small hydrophobic (including aromatic), Blue =Acidic, 
Magneta =Basic, and Green= basic amino acids with hydroxyl groups and/or amine groups. 
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human FOX03a (S324 ), FOX04 (S267), Daf-16a1 (S317), and dFOXO (S248) (Figure 
lB). In addition, the sequence surrounding this site in dFOXO (LS248PI) is identical to 
that in FOXOl. The high conservation ofthis sequence suggests that dFOXO could be 
phosphorylated at this site by the Drosophila homologue ofDYRKlA, minibrain (mnb). 
Binding to 14-3-3 proteins is thought to be important for the sequestration of 
FOXO factors in the cytoplasm [30, 31]. 14-3-3 proteins normally bind to a consensus 
site containing a phosphoserine residue, either RSxSP xP, or RxxxSP xP [39]. In the case 
of dFOXO, the sequence surrounding the Tl Akt phosphorylation site corresponds to the 
motifwith a substitution of threonine for serine. It has been shown experimentally that 
14-3-3 does bind to the Tl site in FOX01 [40], FOX03a [33], and Daf-16 [32], hence, it 
is also likely this region functions as a 14-3-3 binding site in Drosophila. 
The current model for FOXO deactivation suggests the existence of anNES, 
causing constitutive localization of FOXO in the cytoplasm in the absence of a functional 
NLS [31]. A non-conventional NLS was identified in human FOX04 from amino acids 
180-221 [36]. The corresponding sequence in dFOXO (amino acids 147-194) is 38% 
identical and 66% similar in amino acid content (Figure 1 B). This similarity suggests that 
this region may act as an NLS in dFOXO as well. A leucine-rich NES has been 
identified in FOX01 (368 MEN1_LDN1_N1_377) and the conservation ofthis sequence is 
high in FOX03a, FOX04, and Daf-16 [30]. The corresponding region in dFOXO retains 
two ofthe important leucine residues (281 LTGTMADE1_T1_291), however, the 
remaining sequence is more divergent. 
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FOX04 has previously been shown to be phosphorylated in a RaJ-dependent 
manner at threonines 44 7 and 451 [ 41 ]. However, these sites do not appear to be 
conserved in the other human FOXO homologues, Daf-16, or dFOXO, indicating that 
RaJ-dependent phosphorylation ofFOXO may be specific to FOX04. 
dFOXO expression during development phenocopies starvation and alters feeding 
behaviour. 
Drosophila larvae feed continuously up to the age of 5 days after egg laying 
(AEL). During this time the appetite and growth rate of the larvae is enormous. If young 
larvae are deprived of food, they do not grow and tend to disperse randomly [16, 17, 42]. 
When the food supply is replenished, the larvae immediately move towards it and 
continue eating until they approach pupation. If the food supply is again depleted, the 
larvae will disperse again [42]. We utilized the UAS/Gal4 ectopic expression system 
[43] to overexpress dFOXO in the developing larvae under the control of the ActGal4 
driver [44]. This resulted in complete developmental arrest of the larvae, which remained 
as first instar for up to 7 days (Figure 2A), similar to the life expectancy of starved larvae 
[16-18]. This trend was also seen using a constitutively active version of Murine Foxo 1 
(mFoxo1) containing an alanine substitution at the Tl (T24A), and S 1 (S253A) Akt 
phosphorylation sites (mFoxo1-AA) [45] (Figure 2A). In addition, larvae expressing 
dFOXO and mFoxo 1-AA were often found to be wandering far from their food supply. 
We monitored feeding behavior by assessing the number of larvae away from their food 
at 48 and 72 hours AEL. Larvae expressing dFOXO and mFoxo1-AA 
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Figure 2: Expression of dFOXO in first instar larvae phenocopies starvation and influences feeding 
behavior. Expression ofdFOXO and mFoxol-AA early in larval development using the (A)ActGa/4 
and (C) hsGa/4 driver lines leads to developmental arrest similar to that seen in starved larvae. 
Developmentally arrested larvae are capable of surviving for up to seven days after egg laying (AEL). 
(B) Expression of dFOXO (red bars) and mFoxol-AA (green bars) leads to alterations in feeding 
behavior when compared to controls (grey bars). The percentage of wandering larvae is significantly 
greater in larvae expressing dFOXO and mFOXOl-AA at 48 hours and 72 hours AEL (p=0.05). 
Expression of dPI3K-DN (blue bars) did not increase larval wandering. (D) Developmental arrest is 
reversible upon removal of dFOXO expression (red bars), but not upon removal of mFOXO 1-AA 
expression (green bars). Grey bars represent the controls. Each bar reflects the average of three 
separate trials, with 50 larvae per trial. Genotypes are; (A-top, B-grey bars)w; ActGa/4/+, (A-middle, 
B-red bars) w; ActGa/4/+; UAS-dFOXOI+, (A-bottom, B-green bars) w, UAS-mFoxol-AA/w; 
ActGa/4/+, (C-top, D-grey bars) w; hsGa/4/+, (C-middle, D-red bars), w; hsGa/4/UAS-dFOXO, (C-
bottom, D-green bars)w, UAS-mFoxol-AA/w; hsGa/4/+ ,(B- blue bars) w; ActGal4/dPI3K-DN. 
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showed a 3-4 fold increase in wandering over larvae expressing Gal4 alone (Figure 2B). 
Thus, dFOXO expression drastically alters feeding behavior and is able to induce a 
starvation type response in larvae which have an adequate food supply. 
In Drosophila, PI3K consists of an adaptor subunit, dp60, and a catalytic subunit, 
dp 110. Unexpectedly, expression of an inhibitory or "dominant negative" version of 
dp11 0 (UAS-dPI3K-DN) [46] under the control of ActGa/4 did not lead to increased 
larval wandering (Figure 2B). Expression of this construct also did not appear to inhibit 
larval growth, whereas other negative regulators of insulin signalling do [ 18]. The 
inability of this construct to inhibit growth and induce wandering behaviour suggests that 
it does not have a complete dominant negative effect. 
Larvae that are developmentally arrested by starvation are able to resume growth 
upon acquisition offood [17]. We examined iflarvae expressing dFOXO could resume 
growth upon tennination of dFOXO expression. To do this we utilized the hsGa/4 driver 
[47]. dFOXO was expressed in the larvae by heat shock treatment (HST) at 37 degrees 
Celsius for 10 minutes every 24 hours. This treatment was sufficient to inhibit growth 
while allowing controls to survive to adulthood with a 48 hour delay in the time to 
pupation (Figure 2C). When dFOXO expression was discontinued after 2, 4, and 6 days 
ofHST, developmentally arrested larvae were able to recover with decreased levels of 
survival as time progressed (Figure 2D). Significant lethality was also observed in 
controls, suggesting that low survival rates were partially due to expression of Gal4, 
shown to induce apoptosis [48], and/or by the HST itself(Figure 2D). Nevertheless, 
62 
developmental arrest caused by dFOXO is clearly reversible as these individuals could be 
returned to their normal path of development. 
dFOXO pe1jorms an analogous function to C. elegans, Daf 16. 
The formation of dauer larvae in C. elegans is a developmental response to 
nutrient limitation [19]. The dauer larvae provides a temporary defense mechanism 
allowing the nematode to persevere until nutrients are available, at which point 
development can continue. Interestingly, constitutive activation ofDaf-16 by mutation of 
its Akt phosphorylation sites to alanine residues causes obligatory dauer larvae formation 
[ 49]. We found a similar result in the Drosophila larvae using the constitutively active 
mFoxo1-AA [45]. This construct had an effect similar to that of dFOXO when expressed 
under the control of ActGa/4 (Figure 2A), and hsGa/4 (Figure 2C). Upon removal from 
HST, larvae expressing mFoxo1-AA did not resume growth but remained in a state of 
developmental arrest until death (Figure 2D). Although a few larvae did survive to 
adulthood after 2 days ofHST, none ofthe larvae were able to continue development 
after 4, or 6 days ofHST (Figure 2D). Out of 450 larvae examined at all time points, 
only 10 expressing mFoxo1-AA survived, when compared to 110 and 180 for larvae 
expressing dFOXO, and Gal4 alone, respectively. Presumably this occurs because Akt is 
unable to deactivate mFoxo1-AA (Figure 4P), allowing it to continue functioning long 
after expression is induced. Taken together, this data suggests that dFOXO is 
evolutionarily conserved in function, possibly playing a role in the response to nutritional 
adversity, as seen in the formation of dauer larvae in C. elegans. 
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dFOXO inhibits growth through alterations in cell size and cell number. 
Expression of dFOXO in the third instar larvae caused significant lethality, 
however, rare flies that did survive were much smaller than control flies (Figure 3A), 
showing a phenotype similar to that caused by mutations in chico [12], dAkt [14] and dlnr 
[6, 9]. Expression of dFOXO under the control of the ubiquitous low level Gal4 drivers, 
armadillo-Ga/4, and hsGal4 (raised at 25 o C with no heat shock) had very little effect on 
growth (data not shown). In contrast, increasing expression of dFOXO using the hsGal4 
driver in flies raised at 29 o C lead to the development of small adults, which were 
approximately half the weight of control flies (Figures 3B and 3D). Analysis of the 
wings of these flies showed that the wing area was reduced by nearly one third and that 
this reduction was due to a decrease in both cell size and cell number (Figures 3C and 
3D). SEM analysis of the eyes revealed reductions in both ommatidia number and 
ommatidia area, which reflect cell number and cell size, respectively (Figures 3E and 3F). 
These results implicate dFOXO in the control of body size through alterations in cell size 
and cell number. 
Regulation of FOXO by P13K/Akt pathway is conserved between mammals and flies. 
When dFOXO is expressed in the developing eye under the control of the GMR-
Ga/4 driver [50], the eye is smaller, Jacking many ommatidia and nearly all of the 
mechanosensory bristles (Figure 4E). The remaining ommatidia are arranged in the 
typical hexahedral array and cross sectional analysis revealed that all of the normal 
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Figure 3: dFOXO reduces growth through alterations in cell size and cell number. (A) Expression of 
UAS-dFOXO in the third latval instarproduces small flies (left) when compared to controls (right). w; 
hsGa/4/CyO flies were crossed to w; UAS-dFOXO/UAS-dFOXO flies and the progeny were heat 
shocked at 36°C for 4 hours during the early third instar. (B) Flies of the genotype w; hsGa/4/+; UAS-
dFOXO/+ (left) were smaller than w; hsGa/4/+ (right) flies when raised at 29°C. (C) The wings of w; 
hsGa/4/+; UAS-dFOXO/+ flies raised at 29oC were smaller than control wings (scale bar= I mm). (D) 
Flies expressing dFOXO (red bars) also showed a significant reduction in body weight, wing area, cell 
number, and cell size when compared to control flies (grey bars) (p=0.005). (E) Flies expressing 
dFOXO had smaller eyes than control flies (scale bar= 150m), and (F) their eyes were reduced in both 
the number of ommatidia and the area of the ommatidia (red bars) when compared to controls (grey 
bars) Genotypes are; (A-left, B-left, C-top, D-red bars, E-left, F-red bars) w; hsGa/4/+; UAS-
dFOXO/+, (A-right, B-left, C-bottom, D-grey bars, E-right, F-grey bars) w; hs-Ga/4/+. 
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GMR-Ga/4 
GMR-Ga/4 + 
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Figure 4: Regulation of dFOXO through insulin signaling is conserved between mammals and flies. The 
GMR-Ga/4 driver was used to drive the expression of(B) dPI3K-DN, (C) wild type dPI3K, (D) dAkt, (E) 
dFOXO, (I) mFoxo 1, and (M) mFoxol-AA, both alone and in various combinations (F-H, J-L, N-P) as 
indicated through the rows and columns in the figure (scale bar= 150m). Genotypes are: (A) w; GMR-
Ga/4/+, (B) w; UAS-dP13K-DN/GMR-Gal4, (C) w; UAS-dPI3KIGMR-Gal4, (D)w; UAS-dAkt/GMR-Ga/4, 
(E) w; GMR-Ga/4/+; UAS-dFOXO!+, (F) w; UAS-dPI3K-DNIGMR-Gal4; UAS-dFOXOI+, (G) w; UAS-
dPI3K/GMR-Gal4; UAS-dFOXOI+, (H) w; UAS-dAkt/GMR-Ga/4; UAS-dFOXOI+ (I) w; GMR-Ga/4, UAS-
mFoxol/+, (J) w; GMR-Ga/4, UAS-mFoxol/UAS-dPI3K-DN, (K) w; GMR-Ga/4, UAS-mFoxol/UAS-
dPI3K, (L) w; GMR-Ga/4, UAS-mFoxol/UAS-dAkt, (M)w, UAS-mFoxol-AA/w; GMR-Ga/4/+, (N) w, UAS-
mFoxol-AA/w; GMR-Gal4/UAS-dPI3K-DN, (0) w, UAS-mFoxol-AA/w; GMR-Gal4/UAS-dP13K, (P) w, 
UAS-mFoxol-AA/w; GMR-Ga/4/UAS-dAkt. 
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photoreceptor cells are present (Figure 4E, data not shown). Thus, it appears that 
dFOXO expression causes a reduction in the number of cells but does not interfere with 
cellular differentiation and the organization of the ommatidia themselves. We have used 
this eye phenotype to test for interactions between dFOXO and other components of the 
insulin signalling pathway. 
Expression of dPI3K-DNunder the control ofGMR-Gal4leads to the formation 
of relatively normal eyes with fewer and smaller cells [46] (Figure 4B). When dFOXO is 
co-expressed in the developing eye with dPI3K-DN the eye is nearly obliterated (Figure 
4F). In contrast, co-expression of dAkt, and wild type dPI3K with dFOXO causes nearly 
complete rescue of the phenotype, restoring the ommatidia and nearly all of the 
mechanosensory bristles (Figures 4G and 4H). Thus, diminishing PI3K/Akt signalling 
(through overexpression of dPI3K-DN) allows for greater activity of dFOXO, and 
enhancing PI3K/Akt signalling (through overexpression of dAkt or dPBK) leads to 
inhibition of dFOXO activity. Similar results were obtained when overexpressing 
(mFoxol) (Figure 4 1-L), indicating that the regulatory mechanisms between these two 
proteins are conserved and that they are functionally interchangeable. 
Growth effects of dPI3K and dAkt are masked by expression ofmFoxol-AA. 
The constitutively active mFoxo 1-AA construct [ 45] was also expressed in the 
developing eye. Expression of this construct causes a phenotype similar to that of 
dFOXO and mFoxol, with characteristic lack of ommatidia and mechanosensory bristles 
(Figure 4M). When mFoxol-AA is co-expressed with dPI3K-DN the eye is nearly 
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obliterated (Figure 4N), as seen with dFOXO and mFoxol (Figures 4F and 4J). Co-
expression ofmFoxol-AA with dPBK leads to a partial rescue of the phenotype, with 
still an obvious lack of ommatidia and mechanosensory bristles (Figure 40). In contrast, 
co-expression ofmFoxol-AA with dAkt does not cause rescue of the ommatidia or 
mechanosensory bristles (Figure 4P), indicating that this construct is not responsive to 
dAkt signalling. The partial rescue of the dFOXO phenotype by dPBK appears to be 
mediated through alterations in cell size (Figure 5) rather than cell number, as there is 
still an obvious lack of ommatidia and mechanosensory bristles (Figure 40). These data 
indicate that inactivation of dFOXO is required for the full effects of growth mediated by 
dPBK and dAkt. 
dPI3K can increase cell size in the presence of constitutively active Foxo 
To examine the effect of dFOXO overexpression on cell size we measured the 
area of the ommatidia. Expression of dFOXO, mFoxol, and mFoxol-AA caused a 
significant reduction in the area ofthe ommatidia (p=O.OOl) (Figure 5). Expression of 
dPBK caused a significant increase in ommatidia size over wild type (p=O.OOl) (Figure 
5). This result is consistent with previous studies showing that dPBK affects cell size in 
a cell autonomous manner [46]. Co-expression ofdFOXO, mFoxol, and mFoxol-AA 
with dPI3K had no significant effect on the enlarged ommatidia (p=O.OOl) (Figure 5). 
Thus, it appears that FOXO proteins have a very minimal effect on cell size in the 
presence ofhigh levels ofdPBK. Surprisingly, this is the case even with the mFoxol-
AA construct, which is only partially responsive to PBK signalling [ 45]. This indicates 
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Figure 5: dFOXO inactivation is essential for dAkt-, but not dPBK -mediated increases in cell size. 
Ommatidia area was measured as a means to determine the effect ofF oxo overexpression on cell size. 
Expression ofdFOXO (bar 2), mFoxo1 (bar3), and mFoxo1-AA (bar 4) under the control of GMR-
Ga/4 causes a significant decrease in ommatidia area when compared to the expression ofGal4 alone 
(bar 1 ). In addition, GMR -Gal4 was used to drive the expression of dP/3K (bars 5-8), and UAS-dAkt 
(bars 9-12), either alone (grey bars), or in the presence of UAS-dFOXO (red bars), UAS-mFoxol 
(light green bars), or UAS-mFoxol-AA (dark green bars). Two sided t-tests were preformed to 
determine statistical significance (p=0.001). Genotypes are: (1) w; GMR-Ga/4/+, (2) w; GMR-
Ga/4/+; UAS-dFOXOI+, (3) w; GMR-Ga/4, UAS-mFoxol/+, (4) w, UAS-mFoxol-AA/w; GMR-
Ga/4/+, (5) w; UAS-dPI3K/GMR-Gal4, (6) w; UAS-dPI3KI GMR-Ga/4; UAS-dFOXOI+, (7) w; 
GMR-Ga/4, UAS-mFoxol/UAS-dPI3K, (8) w, UAS-mFoxol-AA/w; GMR-Gal4/UAS-dPI3K, (9) w; 
UAS-dAkt/GMR-Ga/4, (10) w; UAS-dAkt/GMR-Ga/4; UAS-dFOXOI+ (11) w; GMR-Ga/4, UAS-
mFoxol IUAS-dAkt (12) w, UAS-mFoxol-AA/w; GMR-Ga/4/UAS-dAkt. 
that the dPI3K mediated increase in cell size can occur through dAkt independent 
mechanisms. 
Expression of dAkt in the developing eye caused a significant increase in 
ommatidia size, similar to that seen with dPI3K (p=O.OOl) (Figure 5). Co-expression of 
dAkt with either dFOXO or mFoxol, caused a slight, but insignificant decrease in the 
size of the enlarged ommatidia (Figure 5). However, co-expression of dAkt with 
mFoxol-AA resulted in ommatidia that were approximately the same size as the 
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ommatidia in eyes expressing Gal4 alone (Figure 5), and significantly smaller than the 
ommatidia in eyes expressing dAkt alone (p=O.OO I) (Figure 5). This indicates that the 
deactivation of FOXO by dAkt is essential for dAkt to induce an increase in cell size. 
dFOXO may reduce cell number through inhibition of the cell cycle and not apoptosis. 
The lack of ommatidia and mechanosensory bristles caused by dFOXO 
expression suggests a reduction in cell number during eye development (Figure 6A). 
Reduction of cell number can occur through either increased cell death, or decreased cell 
proliferation. The Drosophila inhibitors of apoptosis, Diap 1 and Diap2 (data not shown), 
and the baculovirus inhibitor of apoptosis, p35 (Figure 6B), were unable to rescue the 
phenotype caused by dFOXO expression. In addition, acridine orange staining of eye 
imaginal discs expressing dFOXO showed no increase in apoptosis when compared to 
controls (data not shown). Drosophila epidermal growth factor receptor (dEGFR) 
signalling acts to protect differentiated cells from death during eye development [51]. 
We initially thought that the pro-survival effects of dEGFR may be sufficient to suppress 
the phenotype caused by dFOXO overexpression. Co-expression of dEGFR with 
dFOXO, however, does not rescue the dFOXO phenotype as ommatidia and bristles are 
clearly still missing (Figure 6D). Conversely, dFOXO does not appear to affect the 
phenotype of dEGFR overexpression as the general disorganization of the ommatidia 
appears to be the same (Figure 6C). Thus, it appears that these two mechanisms are 
acting independently. Taken together, these results suggest that dFOXO overexpression 
does not cause cell death during eye development, as direct inhibitors of the apoptotic 
70 
Figure 6: dFOXO responds to dRas2 signaling, but not to inhibitors of apoptosis. GMR-Ga/4 was used to drive 
the expression of UAS-dFOXO (A) alone, and in the presence of (B) UAS-p35, (D) UAS-dEGFR, (F) UAS-Ras2Vl4. 
UAS-Rasl"" was also expressed in combination with UAS-mFoxol (G) and UAS-mFoxol-AA (H). Scale bars 
equal I 50 m. Genotypes are: (A) w; GMR-Ga/41+; UAS-dFOXO/+, (B) w; GMR-Gal4/UAS-p35; UAS-dFOXO/+, 
(C) w; GMR-Ga/4/UAS-dEGFR, (D) w; GMR-Ga/4/UAS-dEGFR; UAS-dFOXO/+, (E) w; GMR-Ga/4/UAS-Rasvu, 
(F) w; GMR-Ga/4/ UAS-Ras2V!4; UAS-dFOXO/+, (G) w; GMR-Ga/4, UAS-mFoxol/ UAS-Ras2Vl4, and (H) w, 
UAS-mFoxol-AA/w;G MR-Ga/4/ UAS-Ras2v14 • 
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machinery (p35 and Diapl/2) and a known cell survival factor (dEGFR) were unable to 
rescue the dFOXO-induced phenotype. 
Since inhibition of apoptosis could not rescue the phenotype caused by dFOXO 
overexpression in the eye, we examined if activating the cell cycle could inhibit the 
phenotype. Expression of the E2F and Dp transcription factors has been shown to 
promote cell proliferation in the wing imaginal disc [4]. Co-expression ofE2F and Dp 
with dFOXO was not sufficient to rescue the dFOXO phenotype (data not shown). 
Overexpression of constitutively active dRas 1 ( dRas 1 Vl2) has been shown to induce 
ectopic cell proliferation [52] and G 1/S progression in the Drosophila wing disc [53, 54]. 
Co-expression of dRas1 v12 with dFOXO was lethal, so we used a constitutively active 
version of dRas2 ( dRas2 v14). Although dRas2 has not been characterized for its role in 
cell cycle control, it is possible that it has a similar function to dRas 1. Expression of 
UAS-dRas2 v14 under the control of GMR-Ga14 led to extreme overgrowth of the eye, 
lack of ommatidia! organization, and the formation of huge ommatidia (Figure 6E). Co-
expression of dRas2 Vl 4 with dFOXO was sufficient to restore many of the ommatidia and 
mechanosensory bristles lost through overexpression of dFOXO alone (Figure 6A and 
6F). A similar effect was observed upon co-expression of dRas2 v14 with mFoxo 1 (Figure 
6G). In contrast, the loss of ommatidia and bristles seen upon over expression of 
mFoxo 1-AA was not rescued by dRas2 Vl 4 (Figure 6H). This suggests that dRas2 v14 
inhibits dFOXO through a dAkt phosphorylation-dependent mechanism. 
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1.2.4 - Discussion 
For the most part, the genetic mechanisms that control size in multicellular 
organisms are not well understood [2]. Recently, components of the insulin signalling 
pathway have been shown to regulate body size in Drosophila melanogaster through 
alterations in cell size and cell number [1, 6]. We have identified dFOXO as a negative 
controller of growth and organism size that is regulated by components of the Drosophila 
insulin signalling pathway, dPI3K and dAkt. Through overexpression studies in the 
developing eye, we have shown that dFOXO is regulated by dPBK and dAkt in a manner 
that is consistent with the regulatory mechanisms deduced through studies in C. elegans 
and mammalian cell culture. In addition, overexpression of dFOXO in the larvae reduces 
larval growth, phenocopies the effects of nutritional stress, and causes alterations in 
feeding behavior. With this in mind, we propose that dFOXO is involved in the response 
ofDrosophila larvae to nutritional stress. 
Conservation of FOXO in Drosophila. 
The FOXO homologues appear to play an evolutionarily conserved role in the 
control of cellular processes under conditions of low levels of insulin signalling [30, 31]. 
Our experiments provide three lines of evidence supporting the conservation of this 
mechanism in Drosophila. First, dFOXO shows strong sequence homology to Daf-16 
and the human FOXO homologues (Figure 1B). One significant characteristic is the high 
conservation of the three consensus Akt phosphorylation sites, suggesting that dAkt is 
most likely able to phosphorylate dFOXO in vivo, similarly to that shown in mammalian 
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FOXO homologues [33-35]. Second, our experiments show that dFOXO and mFoxo1 
cause nearly identical phenotypic responses when overexpressed in the developing 
Drosophila eye (Figure 4, 5 and 6). This suggests that the activity of these proteins is 
highly conserved as was observed when the C. elegans FOXO homologue, Daf-16, is 
expressed in mammalian cell culture [32]. Third, the phenotypic effects ofFOXO 
overexpression can be modulated by alterations in the insulin signalling pathway. 
Reduced PBK signalling leads to a drastic enhancement of the phenotype that results 
from expression ofFOXO factors (Figure 4). In contrast, increased PBK/Akt signalling 
tends to mask these phenotypes, in a manner that is dependent on the integrity of the Akt 
phosphorylation sites (Figures 4 and 5). As a result, we believe that regulation ofFOXO 
is conserved in Drosophila and that this will be a very useful system in elucidating the 
function of FOXO transcription factors in a model organism. 
Regulation of size by dFOXO. 
Our results show that ectopic dFOXO expression can mediate reduction in cell 
size and cell number (Figures 3, 4, and 5). However, the mechanisms by which these 
reductions occur are still unclear. Net reduction in cell number may occur through 
decreased cell proliferation or increased apoptosis. Insulin and other growth factors that 
activate PBK and Akt have been implicated as potent survival factors in mammalian cell 
culture [1 0, 11 ]. They prevent cell death, in part, by inhibiting FOXO transcription 
factors. It has also been shown that FOX03a can upregulate expression of the pro-
apoptotic protein Bim [55]. In Drosophila, reduction of insulin signalling can lead to 
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apoptosis in the developing embryo [13, 14, 56, 57]. It is possible that this increase in 
apoptosis is a result of dFOXO activation, however, when dFOXO is expressed in the 
developing eye there is no apparent increase in apoptosis, nor is the phenotype 
suppressed by inhibition of caspases, or by co-expression of a known cell survival factor, 
dEGFR (Figure 6). These apparent discrepancies may be the result of tissue specific 
differences. In mammalian cell culture, induction of cell death by FOXO factors seems 
to be limited to non-transformed haematopoietic cell lineages [31]. In Drosophila, loss of 
dAkt function, inhibition of dPI3K, or overexpression of dPTEN, all induce cell death in 
the embryo [13, 14]. However, in imaginal disc cells lacking Pl3K function, there is no 
increase in apoptosis [58]. Thus, the cells in the embryo and imaginal discs may react 
differently to reduced levels ofPI3K/Akt signalling. Although we do not observe 
induction of apoptosis upon dFOXO expression, it is possible that increased levels of 
dFOXO activity (eg. through dominant negative inhibition ofPI3K) do cause apoptosis. 
Studies in mammalian cell culture have implicated FOXO factors in control of the 
cell cycle through increased expression of the cyclin dependent kinase inhibitor p27Kipl 
[59, 60]. It is possible that the reduction in cell number seen upon dFOXO expression is 
a result of cell cycle inhibition. Co-expression of an activated version of Drosophila 
Ras2 ( dRas2 v14) was sufficient to increase cell number in the presence of dFOXO (Figure 
6). dRasl has been shown to induce growth in Drosophila imaginal discs [52-54] 
through activation of dPBK and the transcription factor dMyc [53]. Although there is 
very little information available about dRas2, it is possible that the function of dRas2 
overlaps with that of dRas 1. Expression of dRas2 Vl 4 in the developing eye does cause a 
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phenotype that suggests overgrowth of cells (Figure 6E), and the dRas2 Vl 4 interaction 
with dFOXO appears to dAkt-like signalling (Figure 6H). This is not surprising 
considering that dRasl [53] and mammalian Ras [61] have both been shown to activate 
PI3K signalling. Interestingly, increasing the cell cycle through overexpression of the 
transcription factors E2F and Dp did not rescue the cell number deficit seen upon 
overexpression of dFOXO (unpublished observations). This suggests the possibility that 
activation of dFOXO may override the function of other growth promoting factors, such 
as dMyc, which mediates dRasl induced G liS progression [53]. Supporting this 
hypothesis, we have observed that increased dAkt-mediated growth is entirely dependent 
on the ability dAKT to inactivate dFOXO (Figures 4P and 5). Furthermore, increased 
dPI3K-mediated growth appears to be dependent on dFOXO inactivation with respect to 
increased cell number, but not cell size (Figures 40 and 5). In humans, inactivation of 
FOXO factors may play an important role in tumor suppression by down regulating 
expression of D-type cyclins, thus inhibiting cell cycle progression and transformation 
[62]. It would be interesting to test the interactions between dFOXO and other cell cycle 
promoters to determine the extent of dFOXO dominance over cell proliferation. 
In addition to its effect on cell number, dFOXO is able to control cell size (Figures 3 and 
5). The ability of dAkt to increase cell size is dependent on dFOXO inactivation, 
however, dPI3K does not need to inactivate dFOXO to increase cell size (Figure 5). The 
difference between dPBK and dAkt might be attributed to greater activity of the UAS-
dP13K transgene. However, expression of these constructs individually yields very 
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similar results (Figures 4 and 5) indicating that this is probably not the case. These 
results suggest that dPBK may control size through dAkt-independent mechanisms. 
P13K/Akt signaling and stress response. 
Studies in C. elegans indicate that insulin signalling is a critical mediator of 
longevity and stress resistance [63, 64]. One of the most well-studied stress responses is 
the Daf-16-mediated formation of the dauer larvae under conditions of starvation and/or 
crowding. Several lines of evidence indicate that dFOXO may play a similar role in 
Drosophila larvae. When Drosophila larvae are deprived of food prior to 70 hours after 
hatching (AH), they live in a state of developmental arrest for several days before they 
eventually die. However, when starved after 70 hours AH, the larvae are able to develop 
into adults that are reduced in size. This alteration in developmental response has been 
termed the '70 hour change' and is likely detennined by the minimum size required for a 
Drosophila larvae to enter pupation [16]. We have mimicked the phenotypes resulting 
from starvation before and after the '70 hour change' through overexpression of dFOXO 
at different stages of larval development (Figures 2 and 3). Ubiquitously high levels of 
dFOXO expression in the early larvae (i.e. before 70 hours AH) leads to developmental 
arrest, whereas heat shock-induced expression of dFOXO during the third instar (i.e. after 
70 hours AH) leads to the development of small adults. The normal development of 
starved larvae can resume upon the acquisition of food. Similarly, developmental arrest 
caused by expression of dFOXO prior to the "70 hour change" can be reversed if dFOXO 
expression is discontinued (Figure 2). Developmental arrest caused by expression of 
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mFoxo 1-AA before the "70 hour change" is not reversible suggesting a constitutive 
starvation type response as seen in C. elegans when Daf-16 phosphorylation sites are 
mutated [ 49]. Interestingly, the reversibility of FOXO-induced arrest has also been 
observed in mammalian cell culture [65]. Under conditions of poor nutrition or 
crowding, larval development does not cease, but the larval period is extended and small 
adults are produced [15]. We have replicated this effect through low-level expression of 
dFOXO during the course of development (Figure 3). Finally, feeding behavior is 
drastically altered in larvae expressing dFOXO (Figure 2), causing them to wander away 
from their food. These larvae are often found crawling on the sides and lids of Petri 
dishes. This response may provide a selective advantage in the search for food as seen in 
C. elegans dauer larvae, which often crawl up to the highest point possible in hopes of 
attaching to passing organisms that could move the larvae to new locations with better 
food supply [19]. Taken together, these results suggest that dFOXO activity may act to 
promote survival during times of nutritional stress in a manner that recapitulates the 
formation of dauer larvae in C. elegans. It is tempting to speculate that dFOXO plays a 
role in the response to other forms of stress, as observed with Daf-16 [63, 64]. 
Mammalian FOXO factors have been implicated in the protective response to oxidative 
stress [66-68] and FOXO factors are upregulated in response to caloric restriction in rat 
skeletal muscle [69]. Thus, it is possible that FOXO factors provide an evolutionarily 
conserved switch, by which an organism can alter its developmental program in order to 
promote survival under harsh conditions. 
78 
Insulin signalling and feeding behavior. 
Previously, it was observed that activation ofPI3K/Akt signalling caused larvae 
to wander away from their food [18]. We have observed a similar effect through 
overexpression of dFOXO, which acts in opposition to Pl3K. Thus, two opposing 
signaling mechanisms produce the same effect. It is possible that exogenous activation of 
PI3K/Akt signalling may lead to depletion of the haemolymph by increasing the cellular 
uptake of nutrients [ 18]. This would lead to increased hunger and cause the larvae to 
wander in search of food. In contrast, exogenous activation of dFOXO could alter the 
'transcriptional profile' of the cell to be similar to that experienced under conditions of 
starvation. This altered transcriptional profile could contribute to larval wandering. 
Thus, dFOXO could induce larval wandering through expression of a sub-set of genes 
that are normally active during starvation, whereas exogenous activation ofPI3K/Akt 
signalling could induce larval wandering by causing physiological changes that lead to a 
false sense of starvation. 
1.2.5 - Conclusions 
We have shown that dFOXO is conserved in sequence and regulatory 
mechanisms when compared to homologues from mammals and C. elegans. Drosophila 
melanogaster provides a powerful tool for the analysis of genes in a whole organism. 
Thus, future studies in this organism should provide new insights into the biological 
function of the FOXO transcription factors. This may have implications to the study of 
cancer and diseases related to insulin, such as diabetes and obesity. Our data, taken 
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together with that of others, suggests that dFOXO plays a protective role in the 
developmental response of Drosophila larvae to nutritional stress. Thus, it is possible 
that dFOXO plays a functional role in response to multiple forms of stress. 
1.2.6 - Methods 
Identification and sequence analysis of dFOXO. 
The human FOX04 gene was used to search the National Center for 
Biotechnology Information genomic data bank for Drosophila homologues. Drosophila 
genomic sequences with high homology to FOX04 were identified and used to search the 
Berkeley Drosophila Genome Project for homologous cDNAs. This procedure allowed 
us to identify the clone, LD05569, which was sub-cloned and sent for sequencing to 
Cortec DNA Laboratories, Inc., Kingston, Ontario. Restriction mapping and sequencing 
revealed a eDNA of approximately 3.6 kb translating into a theoretical protein sequence 
of 463 amino acids (Fig I B). Note that there are two other potential start codons that 
may act as sites for translation initiation, and are located slightly upstream of the start site 
we have identified. 
Creation of transgenic Drosophila lines and overexpression studies. 
mFoxol, and mFoxol-T24AIS253A (AA) clones were generously provided by Dr. 
William H. Biggs III [45] and the dFOXO eDNA, LD05569, was obtained from Research 
Genetics. These eDNA were ligated into the p[PUAST] expression vector for use of the 
UAS/Gal4 ectopic expression system [43]. Transgenic flies were created by injecting 
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p[PUAST]-FOXO constructs in to w 1118 Drosophila embryos. Driver lines, GMR-Ga/4 
[50], heat shock-Ga/4 (hsGa/4)[47], and Act5C-Gal4 (ActGa/4) [44] were obtained from 
the Bloomington stock center, as were the UAS lines UAS-dEGFR, UAS-dRasf12, UAS-
E2F, UAS-Dp, UAS-p35, UAS-Diapl, and UAS-Diap2. UAS-dPI3K and UAS-dPI3K-DN 
( UAS-dpll 0°954A) were generously provided by Dr. Sally Leavers. Heat shock treatment 
was conducted in a 3 7°C water bath. 
Phenotypic analysis. 
All experiments were performed at 25°C unless otherwise stated. For scanning 
electron micrographs, flies were desiccated overnight and coated in gold. Ommatidia 
area was measured using NIHimage 6.2 and each value shown is the mean of9 
measurements, taken from 3 individual eyes. Due to the low survival rate of males 
expressing dFOXO, only females were included in the analysis ofwings and body 
weight. Flies were raised under non-crowded conditions and a minimum of 12 flies were 
weighed individually to determine average body weight. Wing area was measured using 
Image) 1.28u, from the National Institute of Health. Cell size and cell number were 
calculated as previously described [70]. A minimum of I 0 wings were analyzed per 
genotype. For all data, two-sided t-tests were performed to determine significant 
differences at p=0.05 and standard error of the mean is represented by error bars on 
graphs. 
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Feeding behavior and phenocopy of starvation using ActGal4. 
The Gal4 driver line w; ActGal4/CyO was crossed to w1118, w; UAS-dFOXOIUAS-
dFOXO, w,UAS- mFoxol-AA!w, UAS-mFoxol-AA, andyw; UAS-dPJ3K-DNIUAS-
dPJ3K-DN. Since the ActGal4 insertion is not homozygous, we assumed that only half of 
the hatched larvae contained the insertion. This assumption was supported by 
observation of the adults arising from each cross. For w; ActGal4/CyO X wlll8 the 
number of adults produced was nearly equal to the number of hatched embryos, with 
approximately halfbearing the CyO balancer chromosome. For w; ActGal4/CyO X w; 
UAS-dFOXOIUAS-dFOXO and w; ActGa/4/CyO X UAS-mFoxol-AA/w, UAS-mFoxol-
AA only flies bearing the CyO chromosome survived and the number of adults was 
approximately half the number of the total hatched larvae. Small, wandering larvae were 
observed only for w; ActGa/4/CyO X w; UAS-dFOXOIUAS-dFOXO and w; 
ActGa/4/CyO X UAS-mFoxol-AA/w, UAS-mFoxol-AA, and in these crosses, only the 
larvae present in the food were growing. Thus, we assumed that small, wandering larvae 
were ofthe genotypes w; ActGal4/+; UAS-dFOXO/+, and w, UAS-mFoxol-AA/w; 
ActGa/4/+. 
For the feeding behavior assay, embryos were collected on apple juice agar over 
~2 hour time periods, counted, and transferred to a Petri dish with filter paper that was 
soaked in 20% sucrose in PBS. In the center ofthe Petri dish was a small piece of 
standard Drosophila food. At 48 hours AEL the number of hatched eggs was counted to 
account for unfertilized embryos. At both 48 hours and 72 hours AEL the number of 
larvae not on the food were counted. The percent wandering larvae was calculated based 
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on the number oflarvae off the food, the number ofhatched eggs, and the assumption 
that only half of the total larvae contained the ActGa/4 trans gene. The results presented 
are the average from three separate trials. Statistical significance was determined using a 
two-sided t-test at p=0.05 and the standard error of the mean is represented by error bars 
on graphs. Individual values were taken from analysis of approximately 50 larvae. 
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Chapter 1.3 
Drosophila FOXO is required for the early larval response to starvation 
and is regulated by nutrient availability. 
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1.3.1 - Abstract 
The insulin signalling pathway is an evolutionarily conserved mechanism used by 
metazoan animals to regulate growth, metabolism, and behaviour in response to 
environmental cues. The FOXO transcription factors regulate cellular function in the 
absence of insulin signalling. Insulin levels are normally reduced during starvation, thus, 
FOXO may mediate the transcription of genes required for adaptive changes, such as 
altered metabolism and growth. We show that Joss ofFOXO in first and second instar 
Drosophila larvae causes starvation sensitivity. During starvation, we observed an 
increase in dFOXO-mediated transcription of a Juciferase reporter gene. Transcription of 
the luciferase transgene was inhibited upon reintroduction of the larvae to food. FOXO 
was not required for the response of third in star larvae to starvation. However, loss of 
FOXO resulted in a decreased height of pupation, which may indicate a role for FOXO in 
larval wandering. In addition, dFOXO transcriptional activity increased dramatically 
during the wandering stage of the larval life cycle. Although FOXO is not required for 
development of Drosophila under laboratory conditions, it may be essential in nature 
where a consistent food source is not always available. This work provides the first 
evidence of starvation sensitivity due to Joss ofFOXO in Drosophila and highlights the 
importance of the insulin signalling pathway in the response of metazoan animals to 
fluctuations in nutrient availability. 
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1.3.2 - Introduction 
The growth of metazoan animals is regulated by developmental signals and the 
availability of nutrients. The insulin/insulin-like growth factor (IGF) signalling (liS) 
pathway is an evolutionarily conserved signalling system that regulates growth and 
metabolism in response to nutritional cues in mammals and model organisms such as 
Caenorhaebditis elegans and Drosophila melanogaster [1-3]. In mammals, circulating 
insulin levels are reduced in response to starvation and this leads to decreased liS activity 
in the affected tissues, resulting in alterations in growth, metabolism, and feeding 
behaviour [3-5]. When C. elegans are raised under conditions of nutrient limitation, they 
enter an alternate developmental stage called the dauer larvae. The dauer stage is 
characterized by arrest of growth at a sexually immature stage along with altered 
metabolism to increase the storage of fat and increased food searching behaviour [6]. 
Genetic studies have linked the components of the liS pathway in C. elegans to the 
formation of dauer larvae [7 -11]. Drosophila larvae also undergo developmental 
alterations in response to nutritional signals that may be mediated by insulin-like peptides 
[12, 13]. Nearly 80 years ago, Beadle determined that starvation ofyoung Drosophila 
larvae leads to developmental arrest that can last for several days before the larvae dies 
[14]. This developmental arrest can be relieved upon acquisition of food and normal 
development will resume [ 14-16]. In contrast, larvae that are starved in the latter stages 
of development survive to be adults, albeit reduced in size [14, 16]. This change in the 
developmental response to starvation occurs approximately 70 hours after hatching (AH), 
and has been coined the "70 hour change" [14]. There are seven Drosophila insulin-like 
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peptide (diLPs), all ofwhich promote growth when overexpressed during larval 
development [17]. diLPs 2, 3, and 5 are produced in the median neurosecretory cells (m-
NSCs) in the larval brain. Expression of diLPs 3 and 5 in these cells is dependent on the 
availability of nutrients [13]. m-NSC cells have direct connections to the circulatory 
system so that it is likely that levels of diLPs 3 and 5 are reduced during starvation and 
that this may cause reduced growth in developing Drosophila larvae. In supp011 of this 
hypothesis, reducing diLP production by ablation ofm-NSC cells in the larval brain leads 
to the generation of small adults [13]. Thus, it appears that the IIS pathway has an 
evolutionarily conserved role in nutrient sensing. 
Insulin affects growth and other cellular activities by binding to receptor tyrosine 
kinases in the cell membrane. These receptors are activated through autophosphorylation 
of tyrosine residues within the intracellular domain ofthe receptor [18]. This leads to the 
recruitment of adaptor proteins from the insulin receptor substrate (IRS) family, that bind 
phosphotyrosine residues through their phosphotyrosine binding domain (PTB) [2, 19, 
20]. IRSs provide a docking site for phosphoinositide 3'-kinase (PI3K), which 
phosphorylates inositol lipids on the inner surface of the cell membrane, converting 
phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate 
(PIP3) [21]. Generation of PIP3 is negatively regulated by the tumor suppressor, PTEN 
(phosphatase and ten sin homologue on chromosome 1 0), which removes a phosphate 
converting PIP3 back to PIP2 [22]. PIP3 promotes signalling by binding to proteins that 
have a pleckstrin homology (PH) domain. The main downstream effector ofPIP3 is Akt 
(also called protein kinase B), a serine/threonine kinase that contains a PH domain and 
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becomes activated following localization to PIP3 residues at the cell membrane. After 
activation, Akt moves into the cytoplasm and nucleus where it phosphorylates targets 
involved in cell growth, cell survival, and metabolism [23-26]. The primary targets of 
Akt include the forkhead box subgroup '0' (FOXO) family of transcription factors [27-
30]. Akt phosphorylates these transcription factors at three sites, which causes them to be 
sequestered in the cytoplasm. When liS is diminished, Akt is down-regulated and FOXO 
factors are able to move into the nucleus and induce transcription of genes involved in 
cell death, cell cycle arrest, metabolism, and oxidative stress response [27-29]. These 
alterations in gene transcription may be critical to activate the cellular response to low 
levels ofiiS activity. 
Manipulation of liS components in Drosophila has revealed phenotypes that bear 
a striking resemblance to the effects of starvation. Mutations that lead to the complete or 
partial loss-of-function of the Drosophila insulin receptor (dlnR), the Drosophila insulin 
receptor substrate (chico), and Drosophila Akt (dAkt), lead to the generation of small 
adults [17, 31-33], a phenotype that is also typical when larvae are starved after the '70 
hour change'. Inhibition of liS during early larval development through overexpression 
ofPTEN or dominant negative versions ofPBK leads to developmental arrest similar to 
that seen during starvation in first instar larvae [12]. Forced activation ofiiS through 
overexpression ofPBK or dlnr in young Drosophila larvae causes starvation sensitivity, 
suggesting that reduced liS activity is required for maximal survival during starvation 
[12]. Drosophila FOXO (dFOXO) also causes developmental arrest when expressed at 
high levels in first in star larvae [34]. Low levels of expression of dFOXO during larval 
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development or overexpression of dFOXO at high levels during the early third instar (i.e. 
after the '70 hour change') leads to the formation of small adults [34]. Thus, the 
missexpression of dFOXO produces age-dependent phenotypes that copy the effects of 
starvation with respect to the "70 hour change". Furthermore, starvation increases the 
effects of dFOXO overexpression in the developing Drosophila eye, suggesting that 
nutrients can inhibit dFOXO activity [35]. These studies support a model in which 
reduced liS activity leads to activation of dFOXO, resulting in alterations in gene 
transcription that lead to reduced growth and developmental arrest in nutrient-deprived 
larvae. 
dFOXO overexpression does closely mimic the effects of starvation, however it is 
possible that these effects are caused by unusually high expression levels, and are not 
representative of naturally occurring processes. We set out to determine the true 
relevance of dFOXO in mediating the effect of! ow liS during amino acid starvation by 
examining dFOXO loss-of-function mutants and by measuring endogenous dFOXO 
activity during starvation. 
1.3.3 -Materials and Methods 
Fly Stocks and Culture 
FOX021 and FOX025 flies were obtained from Martin Junger and Ernst Hafen of 
the University of Zurich [35]. dFOXO mutants were balanced over the TM6C, Tb 
balancer chromosome containing the Tubby (Tb) marker to aid in selection of specific 
larval genotypes. To create dFOXO mutant heterozygotes and transhomozygotes, w; 
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dFOX021/TM6C and w; dFOXd5!TM6Cflies were crossed together, and tow; 
dFOXO+ ldFOXO+ flies. The resulting larval progeny were selected for analysis based on 
the altered body shape resulting from the Tb marker. As it is difficult to distinguish 
between Tb and non-Tb larvae in the first instar, we waited until 48 hours after hatching 
(AH) before attempting to separate these genotypes. 
FRE-Luc flies were created using the 8xFKltkLuc construct provided by William 
Biggs III [36]. The 8xFKJ tkLuc construct contains the firefly luciferase gene under the 
control of a herpes simplex virus thymidine kinase minimal promoter and eight direct 
repeats of a FOX01 (also known as FKHR1) enhancer sequence, which is referred to 
here as the FOXO recognition element (FRE). This construct was cloned into the 
pP:{CaSpeR-1} transformation vector and injected into the developing germ line of 
white_;_ embryos. Transgenic flies were identified based on red eye colour and a stable 
insertion was isolated on the second chromosome. 
Phenotypic analysis 
All experiments were perfonned at approximately 25°C. Average body weight 
was determined by weighing individual flies. Developmental delay and pupation height 
were determined from multiple vials, containing 20 larvae, which were collected at the 
age of 48 hours (AH). Pupation height was measured from the top of the food source, 
which was approximately equal in each vial. Each vial was considered an experimental 
unit for the determination of the standard error of the mean, which is represented by error 
bars on graphs. 
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Starvation Assay 
Flies were allowed to lay eggs on apple juice agar overnight. In the morning, 
plates were collected and hatched larvae were removed. Within the next six hours newly 
hatched larvae were transferred to 1 0 em Petri dishes containing standard Drosophila 
media (cornmeal/molasses/yeast extract/agar). A maximum of 150 larvae were kept per 
plate to avoid crowded conditions. Since all larvae collected are hatched within a six 
hour time frame the age after hatching is calculated from the mid-point of the six hour 
time frame ± three hours. At the appropriate age, larvae were rinsed with a sucrose 
solution and placed into 5-6 mL of20% sucrose in phosphate buffered saline (pH 7.4) in 
a 6 em Petri dish as described by Britton et al. [15]. 30-40 larvae were placed in each 
dish and the media was changed every one to two days. Each dish was considered an 
experimental unit for the determination of the standard error of the mean, which is 
represented by error bars on graphs. 
Luciferase Assay 
Luciferase assays were done using the Luciferase Assay System produced by the 
Promega Corporation. Larvae were collected in samples often and frozen in a -70°C 
ethanol bath. Protein extracts were performed according to the Promega Luciferase 
Assay System manual. Frozen larvae were thawed in 100 ~L, or 200 ~L for larvae older 
than 72 hours AH, ofPromega 'cell culture lysis reagent' (CCLR) and ground with a 
pestle. Samples were frozen and thawed 3 times in a -70°C ethanol bath and a 37°C 
water bath and then centrifuged for 5-10 min. The supernatant was transferred to a new 
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tube and the pellet was ground again in an equal volume of CCLR. The sample was then 
recentrifuged and the resulting supernatant was combined with the first supernatant to be 
stored at -70°C. 
The total protein concentration of extracts was determined using the Biorad De 
Protein Assay Kit that is based on the Lowry assay [37]. Absorbance was read at 750 nm 
using a Spectramax I90 microplate reader (Molecular Devices) and protein concentration 
was estimated in J..Lg/mL from absorbance readings using a standard curve derived from 
known concentrations ofBSA dissolved in CCLR. Protein extracts with absorbance 
readings that were higher than those within the range ofthe standard curve were diluted 
I 0-fold in order to accurately estimate protein concentration. Luciferase activity of larval 
protein extracts was measured using a Top Count NXT microplate scintillation and 
luminescence counter. IOO J..LL ofPromega Luciferase Assay Reagent was added to 20 
J..LL of larval extract and light production was measured in relative light units (RLU) 
emitted over a I 0 second time period. Final values on all graphs are normalized to the 
protein concentration and presented as RLU/J..Lg of protein, with the standard error of the 
mean represented by error bars. 
1.3.4 - Results 
dFOXO loss-of-function mutants are developmentally delayed and sensitive to amino 
acid starvation. 
Previously, we observed that overexpression of dFOXO in young Drosophila 
larvae results in a phenotype that is similar to that observed in larvae undergoing 
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starvation [34]. This suggests that dFOXO may play a role in the response of Drosophila 
larvae to amino acid starvation. As overexpression of dFOXO may not reflect a 
physiological response we examined the phenotypes associated with loss of dFOXO 
activity. dFOX021125 transhomozygous mutants were analysed to avoid the effects of any 
possible second site mutations that may have arisen during the EMS mutagenesis 
• • ?] ?5 21125 procedure used m the creat1on of the dFOXO' and dFOXO- alleles [35]. dFOXO 
mutants survive to adulthood, but show defects in growth control and are sensitive to 
oxidative stress [35]. In addition, dFOX021125 mutants are developmentally delayed by 
• ? II+ ?51+ d d Q+l+ approximately one day when compared to dFOxo- , dFOXO' , an 'FOX, 
controls (Figure IA). 
To determine the importance of dFOX021125 during the larval response to 
starvation, we monitored the survival of dFOXO mutants under conditions of amino acid 
starvation. dFOX021125 larvae are sensitive to amino acid starvation when compared to 
d +/+ . ?5/+ 'FOXO heterozygotes and dFOXO control larvae (F1gure I B). dFOxo- , 
dFOXd11+, and dFOXO+I+ larvae all had comparable survival curves during amino acid 
starvation and reached 50% mortality between days 7 and 8 when starved at the age of 48 
hours AH. In contrast, dFOX021125 mutants reached 50% mortality at approximately 
three days under the same conditions. Due to the apparent developmental delay observed 
with these mutants, we were concerned that the difference in survival may be due to 
differences in developmental stage rather than the loss of dFOXO. To test this, we 
examined dFOXO+I+ control larvae that were transferred to starvation medium at 24 
hours AH and found that they reached 50% mortality at approximately 5 days of 
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Figure 1: dFOXO mutant larvae are developmentally delayed and show sensitivity to 
amino acid starvation. A) The number of days for larvae to reach pupation was determined 
from the time of larval hatching for the genotypes: 11·: dFOXO' , 11': dFOXO'' , 11·: 
dFOXO" ·,and ll'; dFOX0' 1''. dFOX0'1 ·"'mutant larvae take significantly longer (about 1 
day) to reach pupation than do dFOXO heterozygotes and dFOXO larvae. Common 
letters indicate a lack of significant difference as judged by at-test (p=0.05) B) Larvae of 
the genotypes w; dFOnr . w; dFO.\D' 1 ·, w: dFOXO'' , w; dFOX0' 125 were collected at 
48 hours AH and starved of amino acids in a 20% sucrose solution. dF0_\'0'125 mutants 
(squares) died earlier than the dFOX0'1 larvae (open triangles), d FOXCF · larvae (closed 
triangles), and the 48 how· old dFO)l'O- -controls (open circles). To account for differences 
in developmental time dFOXO larvae were collected and starved at 24 hours A H (closed 
circles). 24 hour old larvae die sooner than the 48 hour old controls, but lived longer than 
the dFOX0'1 "mutant larvae. 
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amino acid deprivation (Figure lB). The 24 hour AH dFOXO+I+ control larvae appeared 
to be approximately the same size as the 48 hour AH dFOX021125 larvae, to indicate that 
these two groups were likely at a similar stage of development. The 24 hour AH 
dFOXO+I+ larvae did have a reduced length of survival during amino acid starvation, 
compared to the older control larvae, yet they lived approximately 40% longer than the 
dFOX021125 mutants (Figure lB). This data suggests that dFOXO plays an important role 
in the ability of young Drosophila larvae to withstand the stress of nutritional deprivation. 
dFOXO transcriptional activity is increased during starvation. 
The sensitivity of dFOX021125 mutants to amino acid starvation suggests that 
dFOXO is required to mediate transcription of genes that promote survival during 
starvation. To monitor dFOXO-mediated transcription, we used a FOXO recognition 
element (FRE) in conjunction with the firefly luciferase gene as a detectable marker [36]. 
To verify that dFOXO is involved in mediating transcription from the FRE-Luc transgene 
we tested luciferase activity in protein extracts of dFOXd1125 larvae (Figure 2D). Protein 
extracts from dFOXd1125 larvae had reduced luciferase activity in response to 24 hours of 
amino acid starvation when compared to dFOXO+I+ controls (24 and 48 hours AH) and 
the dFOXO+I- heterozygotes (Figure 2D). These differences were statistically significant 
(p=0.0007, 0.0260, 0.0055) except for dFOX0251+ (p=0.080), which had a similar mean to 
the other controls but showed high variability. The residualluciferase activity seen in the 
absence of dFOXO may be due to maternally inherited dFOXO or to other factors that 
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Figure 2: dFOXO transcriptional activity is controlled by amino acid availability. FRE-Luc 
larvae (genotype: w; FRE-Luc!FRE-Luc) were subjected to amino acid starvation at (A) 24 
and (B) 48 hours AH. (A-B) These larvae survived for several days (circles-right axis) and 
were analysed for luciferase activity on a daily basis during this time. Luciferase activity 
increased dramatically in response to amino acid withdrawal (squares-left axis). (C) 
Luciferase activity is decreased after the return of starving larvae to food (squares-left axis). 
Growth resumed after the placement on food as indicated by an increase in protein 
concentration in larval extracts (triangles-right axis). Luciferase activity decreased 
significantly by 24 hours after refeeding and was completely abolished within 48 hours. (D) 
dFOXO is required for the full response of the FRE-Luc transgene to starvation. Larvae of 
genotypes, w; FRE-Luc; dFOX(r -, w; FRE-Luc; dFOXOc 1 • w; FRE-Luc; dFOX0'5 ",and w; 
FRE-Luc; dFOX(f :5 were st.1rved for 24 hours. dFOXOc1 25 larvae had significantly less 
luciferase activity than dFOX0 21 " larvae (p=0.0055). and dFO.'(()-- larvae that were starved 
at 24 hours AH (p=0.0007) and 48 hours AH (p=0.026). dF()) . '(/5 · larvae did show higher 
luciferase activity than the dFOX0 2125 mutants, however, this difference was not statistically 
significant (p=0.080). 
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can influence gene expression from the FRE in response to amino acid withdrawal. 
However, dFOXO is clearly required for the full transcriptional activation of the FRE-
Luc construct, as luciferase activity is 75-85% greater in the presence of two copies of the 
intact dFOXO gene. 
FRE-Luc larvae were subjected to amino acid starvation at 24 hours AH (Figure 
2A) and 48 hours AH (Figure 2B), and reached 50% survival at approximately 6 and 7 
days AH respectively, which is comparable to controls examined above. During amino 
acid starvation, luciferase activity increased dramatically in protein extracts of FRE-Luc 
larvae (Figure 2A,B). Significant increases were seen as early as one day post amino 
acid withdrawal (Figure 2A,B,D) and appeared to plateau after 2 days (Figure 2A,B). 
This suggests that dFOXO actively promotes transcription during amino acid starvation. 
The developmental arrest of Drosophila larvae in response to starvation is 
reversible upon acquisition of a suitable food source [ 14, 16]. Correspondingly, the 
observed increase in dFOXO activity upon amino acid withdrawal is also reversible 
(Figure 2C). Larvae were fed for 24 hours, and then transferred to starvation media for 
two days before being returned to food. Within 2 days of the return to complete medium, 
larval growth resumed, and is reflected by an increase in the protein concentration of 
larval extracts (Figure 2C). During this period of growth initiation, luciferase activity 
dropped dramatically, to reach basal levels within two days (Figure 2C). The 
responsiveness of the FRE-Luc trans gene to the availability of amino acids suggests that 
dFOXO transcriptional activity is modulated in response to nutritional cues. 
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dFOXO does not affect the survival of larvae starved after the '70 hour change'. 
We demonstrated that forced expression of transgenic dFOXO after the '70 hour 
change' does not cause developmental arrest but leads to the generation of small adults 
[34]. This phenotype is similar to that observed upon starvation of larvae after 70 hours 
of development (Figure 3A) [16] and through loss of liS components such as chico, dAkt, 
and dlnR [31-33]. FRE-Luc flies that were starved at 80 hours AH showed a significant 
reduction in size when compared to controls that were not starved (Figure 3A) and 
showed a large increase in luciferase activity in protein extracts taken 24 hours after the 
onset of starvation (Figure 3C). This suggests that dFOXO is active during starvation in 
?J/25 the later stages of larval development, however, dFOXCY mutants do not appear to be 
sensitive to starvation at this age (Figure 3B). Between 80% and 90% of control larvae 
d +/+ d +/+ d ?]/+ d 751+) d . ft . ( 'FOXO , FRE-Luc; 'FOXO · , 'FOxo- , 'FOXCY un ergo pupation a er ammo 
acid starvation at 80 hours AH (Figure 3B). Only 40% of dFOX021125 larvae reached 
pupation when starved at 80 hours AH, however these larvae were smaller than the 
• ?J/?5 
controls due to developmental delay. At 96 hours AH, pupatiOn of dFOxo- - larvae 
reached 94%, suggesting that the reduced pupation at 80 hours AH is indeed a result of 
developmental delay. Although dFOXO appears to be activated in response to starvation 
after the '70 hour change' (Figure 2C), it is not required for the adaptive responses 
observed in larvae at this age (Figure 3B). 
Larval crowding affects adult size but not dFOXO activity. 
Low expression levels of dFOXO during larval development lead to reduction in 
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Figure 3: dFOXO is active during amino acid starvation after the 70 hour change, but is not required 
for maximal survival. (A) The weight of male and femalnv; FRE-Luc adults was measured for fed 
larvae and larvae that were starved at 80 hours AH. (B) The percentage of larvae undergoing 
pupation after starvation at 80 hours A H was measured for the genotypes, >v: dFOXU , w: FRE-
Luc;dFOXO , w: dFOX0'1 , w;dF()){(/' , and w;dFOX021 ". dFOX0 21 25 larvae showed reduced 
pupation at 80 hours AI-l, but not at 96 hour AI-l, suggesting that the reduction at 80 hours AI-l is due 
to developmental delay. (C) Luciferase activity was calculated in protein extracts from w; FRE-Luc 
larvae immediately before the onset of starvation (0 hours) and 24 hours after initiation of starvation 
at 80 hours AH. (D) Body weight of male and female w; FRE-Luc adults was determined from 
larvae that had been raised under variable conditions of crowding with 20 (clear), 50 (black), 100 
(h01izontallines). 200 (checkers). and 500 (veJticallines) larvae per vial. Body weight is reduced 
as the num beroflarvae pervial increases. 
110 
the size of adults [34]. We speculated that this low level of expression may reflect a 
situation such as larval crowding, which also causes the generation of small adults 
(Figure 3D). We found that FRE-Luc flies were significantly reduced in size when the 
number of larvae per vial was increased from 20 to 100, 200, and 500 (Figure 3D). 
However, we did not notice an increase in luciferase activity in larvae that were crowded 
at 200 larvae per vial (data not shown) suggesting that other factors may be responsible 
for the reduction in larval growth during crowded conditions. 
dFOXO activity is increased in the wandering third instar larvae and may influence 
larva/wandering. 
We examined the luciferase activity in protein extracts from fed FRE-Luc larvae 
over the course of larval development and noticed that there was a dramatic increase in 
dFOXO activity during the wandering stage ofthe third instar larvae, at 102 hours AH 
(Figure 4A). We examined luciferase activity in protein extracts from wandering 
dFOXd1125 mutant larvae and found that it was significantly reduced when compared to 
dFOXO~I+ larvae (Figure 4B). Due to the variability in development time in these lines, 
larvae were selected for comparison based on advancement into the wandering stage 
rather than selection at 102 hours AH. Thus, it appears that dFOXO is required for the 
full activation of the FRE-Luc transgene in the wandering third instar larvae. In addition, 
dFOXd1125 mutants had a lower height of pupation than dFOXO+I+ larvae (Figure 4C), 
suggesting that dFOXO may influence wandering behaviour during the late third instar. 
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Figure 4: dFOXO is active during larval wandering and may effect wandering 
behaviour. (A) Luciferase activity was determined in w; FRE-Luc larvae at 24, 
48, 72, 78, 96 and 102 hours A H. Luciferase activity remained at the basal level 
until! 02 hour AH during the onset oflarval wandering. (B) Luciferase activity 
was measure in wandering stage larvae of genotypes. w; FRE-Luc and •r; FRE-
Luc; dFOX0'1 25 • The luciferase activity observed during wandering was 
reduced in a dF0_\'0 21 25 mutant background when compared to w; FRE-Luc: 
dFOXO · controls. (C) Pupation height was measured as the distance traveled 
from the top of the fl.1od in vials containing 20 larvae of the genotypes w; 
dFOXO- +'and w; dFOXOm 5• dFOX021 "5 larvae climbed significantly less than 
the controls larvae (p<O .0001 ). 
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1.3.5 Discussion 
The growth of metazoan animals during development is controlled by an array of 
signalling events that are influenced by cellular and environmental factors. The 
availability of nutrients is one ofthe key factors influencing growth, yet we are only 
beginning to unravel the signalling mechanisms involved in the relay of dietary 
information to individual cells. Our work in Drosophila has revealed a FOXO-mediated 
transcriptional response to starvation that suggests an evolutionarily conserved role for 
the liS pathway in the relay ofnutritional signals. 
The role of dFOXO in the response of young Drosophila larvae to starvation. 
We have shown that dFOXO is required for maximal survival and enhances 
transcription through FOXO recognition elements during periods of starvation in first and 
second instar larvae (Figures I, 2). There are several mechanisms through which 
dFOXO-mediated transcription could enhance the survival of starving larvae. One 
possibility is that dFOXO induces cell cycle arrest in larval endoreplicative tissues, thus 
allowing stored nutrients to be used to favor the maintenance of adult forming tissues 
such as the central nervous system and the imaginal discs. Several lines of evidence 
support this. First, forced activation of insulin signalling in starved larvae bypasses the 
cell cycle arrest that is normally observed and leads to starvation sensitivity similar to 
that seen in dFOXO mutants [12, 15] (Figure IB). Second, overexpression of dFOXO in 
first instar larvae causes developmental arrest that is very similar to that observed in 
starved Drosophila larvae [34]. Third, mammalian cell culture studies have suggested a 
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role for the FOXO homologues in transcription of genes involved in cell cycle arrest. 
Expression of mammalian FOXO in cultivated cells causes G 1 cell cycle arrest by 
inducing expression ofp27KIPI [38-41], and possibly by promoting the stability ofp27KIPI 
post-translationally [42]. Mammalian FOXO homologues have also been implicated in 
the expression of p130, thought to contribute to cell senescence [43], and cyclin G2, a 
marker for G0 that inhibits cell cycle entry [44]. In addition, FOX03a can promote G2 
cell cycle arrest through transcription of GADD45 in response to oxidative stress [ 45]. 
FOXO also may inhibit the cell cycle by down-regulating the expression of cyclins Dl 
and D2, both required for cell cycle progression [46, 47]. dFOXO has not been directly 
implicated in the control of cell cycle in Drosophila, however, it is highly conserved in 
sequence and has been implicated in growth reduction [34, 35, 48]. Thus, dFOXO may 
reduce growth by increasing transcription of cell cycle inhibitors in Drosophila, such as 
the p27KIPI homologue, dacapo [49]. 
dFOXO is activated during starvation after the '70 hour change' but is not required for 
survival. 
We found that dFOXO is not required for the survival of larvae that are starved 
after the '70 hour change', despite an increase in transcription from the FRE promoter 
(Figure 3). Our previous studies showed that overexpression of dFOXO reduced the 
growth of larvae after the '70 hour change' leading to the formation of small adults [34]. 
While the phenotype resulting from dFOXO overexpression in these experiments does 
114 
highlight a role for dFOXO in the reduction of growth, our data suggests that this is not 
the mechanism used for starvation-induced reductions in adult size (Figure 3). 
Why is dFOXO required for starvation resistance before, and not after the '70 hour 
change'? The answer may lie in the tissue specific modulation of signalling pathways in 
larval endoreplicative tissues, which do not form adult structures, and larval imaginal 
tissues, which eventually develop into adult structures (Figure 5). The larval fat body is 
thought to be a nutrient sensing organ in Drosophila larvae [15, 50]. In response to 
amino acid uptake, the larval fat body produces ALS (acid labile subunit), which enters 
into circulation and may act to stabilize dlLPs and increase liS activation in peripheral 
tissues [50]. Both starvation and inhibition of amino acid uptake in the fat body cause a 
decrease in expression of ALS. This leads to inhibition of liS activity in larval tissues, 
but not in the adult forming tissues, such as the imaginal discs or central nervous system 
(CNS) [50]. liS signalling may be maintained in the adult forming tissues through 
nutrient-independent expression of diLP2, known to be expressed in the imaginal discs 
and the CNS [17]. The response of young Drosophila larvae to starvation requires 
inhibition of cell cycle progression in larval tissues, thus, the loss of dFOXO may lead to 
starvation sensitivity at this stage of development. In contrast, starvation of older larvae 
results primarily in a reduction in size of adults. Since dFOXO is likely inhibited in adult 
forming tissues during starvation, its absence would have minimal effect on the survival 
activity in crowded larvae (Figure 3D) and why dFOXO null mutants show no visible 
growth defects under normal conditions [35]. An alternative mechanism that may be 
involved in the regulation of adult size in response to starvation or crowding is the TOR 
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pathway. The TOR pathway is an evolutionarily conserved nutrient sensing system that 
is controlled by liS and/or the availability of amino acids [51]. Thus, the liS system may 
use multiple downstream targets, including dFOXO and TOR, to regulate tissue specific 
growth control in response to nutrient deprivation. 
The role of dFOXO in larval wandering 
We observed a large increase in dFOXO activity during the wandering stage of 
third instar larvae (Figure 4A,B). The survival of dFOXO mutants to adulthood suggests 
that dFOXO plays a minimal role during the process of wandering and pupation [35]. 
However, it is possible that dFOXO contributes to these processes in a minor or 
redundant manner, as dFOXd1125 mutants show a decrease in wandering distance whole 
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searching for a pupation site (Figure 4C). In addition, overexpression of dFOXO in first 
instar larvae causes them to wander away from their food, suggesting that a high level of 
dFOXO expression is sufficient to induce wandering [34]. Although dFOXO is not 
required for wandering, it may contribute to the ability or desire of larvae to wander by 
mediating alterations in metabolism or neuronal signalling. As FOXO family members 
have been implicated in the transcription of metabolic genes [52], the loss of dFOXO 
may result in inefficient metabolism and a decrease in the amount of energy available for 
wandering. Alternatively, dFOXO may become active in neuronal cells to produce direct 
effects upon behaviour in the CNS. The ability of dFOXO to promote wandering may 
result from an evolutionarily conserved mechanism allowing organisms to seek out 
alternate food sources in response to low nutrient intake. 
Cell signalling pathways are important for the response of metazoan animals to 
environmental factors such as nutrient availability. Our data supports a model in which 
the liS pathway is reduced during starvation leading to alterations in development and 
behaviour that are mediated in part by the FOXO family of transcription factors. 
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Chapter 1.4: Summary and Conclusions 
125 
The FOXO transcription factors are central regulators of cell function in the 
absence of insulin signalling. These factors interact with other transcription factors to 
regulate the expression of genes involved in growth, metabolism, longevity, oxidative 
stress resistance, and starvation response. The previous chapters, 1.2 and 1.3, describe 
the analysis of the FOXO family oftranscription factors in Drosophila melanogaster. 
This work has established Drosophila as a suitable model for the analysis ofFOXO 
tlunily members and has provided novel insight into the role of dFOXO in the regulation 
of starvation response and larval wandering. 
The identification of dFOXO using bioinformatics served as a starting point for 
this research, providing verification that dFOXO is the only homologue ofFOXO in 
Drosophila, and that it retains the forkhead box DNA binding domain and Akt 
phosphorylation sites observed in mammalian homologues. To further analyze the 
function and regulation of these transcription factors in Drosophila, we have employed 
three main experimental strategies; overexpression, analysis of endogenous dFOXO 
activity, and loss of function analysis. Taken together, these experiments have 
demonstrated that dFOXO; I) regulates growth through PBK/Akt-dependent signalling, 
2) is involved in the regulation of starvation response, and 3) promotes larval wandering. 
The characterization of dFOXO provides a basis for future research aimed at 
identification of the physiological mediators ofFOXO function. 
Overexpression ofdFOXO and mFoxol in the developing eye ofDrosophila 
produces a distinct phenotype that is characterized by a loss of ommatidia and 
mechanosensory bristles. This phenotype is rescued by coexpression ofPI3K and Akt, 
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and exacerbated by coexpression of a 'dominant negative' mutant ofPI3K. PI3K and 
Akt are unable to fully rescue the phenotype induced by overexpression of a mutant 
version ofmFoxol that is constitutively active due to the alteration of its Akt 
phosphorylation sites by in vitro mutagenesis. These experiments verify that Drosophila 
FOXO is a downstream target ofthe Pl3K/ Akt signalling pathway and is inhibited upon 
phosphorylation by Akt. 
There are two main adaptations of Drosophila larvae to starvation and the 
ubiquitous expression of dFOXO during larval development can mimic the phenotypic 
consequences of these adaptations. First and second instar larvae undergo developmental 
arrest during amino acid starvation that is reversible upon the acquisition of food. When 
third instar larvae are starved, they continue through the stages of development, but give 
rise to adults that are reduced in size. dFOXO overexpression in young larvae causes 
developmental arrest, while dFOXO overexpression in third instar larvae gives rise to 
adults that are reduced in size. Analysis of the transcriptional activity of a reporter gene 
directed by FOXO recognition elements revealed that dFOXO transactivation of gene 
expression is increased during amino acid starvation and is decreased when larvae are re-
fed. Analysis of dFOXO loss of function demonstrated that dFOXO is required for the 
survival of larvae to starvation in the first instar, but not the third instar. Although 
dFOXO loss of function during the starvation of first in star larvae causes a 40 to 60 
percent reduction in the duration of survival, the Joss of dFOXO function in the third 
instar has no effect on survival. The effect of dFOXO loss-of-function on body size after 
starvation in the third instar has not been measured. This effect should be measured to 
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get a full understanding of the importance of dFOXO during starvation after the '70 hour 
change'. 
Nutrient withdrawal is known to affect food searching behaviour in Drosophila. 
For instance, when Drosophila larvae deplete a food source, they tend to disperse. 
Interestingly, overexpression of dFOXO causes larvae to disperse when food is plentiful, 
to suggest that dFOXO induces larval wandering. Interestingly, endogenous dFOXO 
activity is increased dramatically during the wandering stage, near the conclusion of 
larval development. Loss of function of dFOXO does not eliminate larval wandering, but 
does result in reduction of the vertical distance traveled in search of site for pupation. 
Taken together, these results suggest that dFOXO expression can promote larval 
wandering, through an undetermined mechanism. 
In conclusion, Chapters 1.2 and 1.3 contribute to the growing body of evidence 
demonstrating the evolutionary impmtance of the liS signalling pathway in the response 
of metazoan animals to fluctuating nutrient availability. These experiments provide a 
basis for future research examining genes that mediate the physiological functions of 
dFOXO. One candidate is 4EBP, a transcriptional target of dFOXO that mediates the 
effects of dFOXO in promoting resistance to oxidative stress [1]. It would be interesting 
to learn if 4EBP is important in mediating the effect of dFOXO on starvation resistance 
and growth. dFOXO has also been implicated in the extension of lifespan [2, 3] and can 
delay aging related defects of the heart [4]. Is 4EBP involved in all ofthe functions of 
dFOXO or are there other important targets? Most likely there are many important 
targets. Novel targets could be identified through large scale genetic screens looking for 
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modifiers of dFOXO phenotypes. A screen looking for modifiers of the dFOXO eye 
overexpression phenotype presented in Chapter 2.2 could reveal novel targets of dFOXO 
that are involved in important processes such as aging and growth and stress resistance. 
Now that dFOXO has been characterized in this thesis [5, 6] and in the work of others [2-
4, 7-9] it is possible to use the true power of Drosophila genetics to advance knowledge 
of the cellular control of aging, stress resistance, and diseases such as obesity and 
diabetes. 
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Chapter 2 
Toxic Effects of Gal4 Expression in Drosophila 
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Chapter 2.1 
Introduction and Overview 
132 
The UAS/Gal4 ectopic expression system is an important tool for the 
overexpression of genes in Drosophila melanogaster [1, 2] (Figure I). This system 
utilizes the yeast transcription factor Gal4, which activates transcription of genes through 
an upstream activation sequence (UAS) in the promoter region of selected genes. 
Conveniently, the UAS consensus sequence (CGGAGTACTGTCCTCC) is not contained 
in the genome of D. melanogaster (Berkeley Drosophila Genome Project, personal 
communication). In theory, this allows for the expression of Ga/4 in flies with little 
effect. Since the introduction of the UAS/Gal4 system, many transgenic Drosophila 
strains, called 'driver lines', have been created that express Ga/4 under the control of 
Drosophila promoters. Ga/4 expression profiles have been characterized by reporter gene 
analysis and in situ hybridization, and in many cases, expression is regulated both 
spatially and temporally [I, 2]. In tandem, conditionally responsive transgenic flies 
called 'UAS lines' can be generated that contain specific sequences under the control of 
UAS containing promoters [2]. Thus, tissue specific overexpression of genes in 
Drosophila can be achieved by simply crossing 'driver lines' with 'UAS lines'. 
Currently, there are hundreds of different 'UAS lines' and Gal4 'driver lines' that are 
publicly available in the Bloomington Drosophila Stock center at Indiana University. 
The relative simplicity ofthe UAS/Gal4 system, combined with the free availability of 
pre-existing stocks, makes this a popular and powerful technique to employ for genetic 
experiments. 
In Chapter 1.2 we made extensive use of the GMR-Ga/4 driver [3] line to express 
dFOXO and other signalling genes in the developing eye [4]. Since cell culture studies 
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Figure 1: Schematic diagram of the UAS/Gal4 ectopic expression system. Sec text for details. 
have implicated FOXO factors in the expression of genes involved in apoptosis [5-7], we 
searched for apoptosis in the eye imaginal discs ofGMR-Gal4/UAS-dFOXO flies [4]. 
Upon examining the controls for these experiments, we noticed larvae with two copies of 
the GMR-Ga/4 transgene had a great increase in apoptosis in the region of the imaginal 
disc posterior to the morphogenic furrow, where Gal4 is expressed [3, 8]. This inspired 
us to do a more thorough analysis of the effects of GMR-Ga/4 on eye development, 
revealing temperature-sensitive effects of Gal4 on the formation of a rough eye 
phenotype and increased apoptosis in the eye imaginal discs (Chapter 2.2) [8]. In 
addition, we have shown that the rough eye phenotype and apoptosis that are induced by 
Gal4 can be suppressed by p35, an inhibitor of caspase mediated apoptosis (Chapter 2.3) 
[9]. As a result, we conclude that Gal4 acts as a toxic protein with the capability to 
activate the cellular apoptotic machinery when expressed at high levels. 
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As of September 2005, Flybase lists 238 references that utilize the GMR-Ga/4 
line, yet our report appears to be unique in our attempt to address the potential problems 
with this line. The activation of cell death in GMR-Gal4 flies indicates that Gal4 could 
cause apoptosis in other 'driver lines'. Experiments in our lab have shown that Gal4 has 
detrimental effects on lifespan when expressed in the dopaminergic neurons with or 
without a responsive gene target [1 0]. Reduced lifespan in these flies may be a result of 
Gal4-induced neuronal cell death. Thus, the experiments presented in chapters 2.2 and 
2.3 provide important information that should be taken into consideration during the 
planning and execution of any experiment using the Gal4 system. 
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Chapter 2.2 
GAL4 causes developmental defects and apoptosis when expressed in 
the developing eye of Drosophila melanogaster. 
A version ofthis chapter is published as: 
Kramer, J.M., and Staveley, B.E. (2003). GAL4 causes developmental defects and 
apoptosis when expressed in the developing eye of Drosophila melanogaster. Genet Mol 
Res 2, 43-47. 
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2.2.1 - Abstract 
The UAS/GAL4 ectopic expression system is widely used in Drosophila 
melanogaster for the overexpression oftransgenes. This system operates under the 
assumption that the yeast transcription factor, GAL4, is inactive in Drosophila. Thus, 
GAL4 can be expressed using Drosophila-specific promoters with little effect on the 
organism. We have shown that expression ofGAL4 in the developing eye using the 
glass multiple reporter (GMR) promoter element can cause defects in eye development. 
Although flies with one copy ofthe GMR-GAL4 transgene appear normal when raised at 
25°C, those with two copies have a highly disorganized ommatidia! array. In addition, the 
levels of apoptosis in the third in star eye imaginal disc (where GAL4 is being expressed) 
are slightly higher in GMR-GAL4 heterozygotes, and much higher in GMR-GAL4 
homozygotes when compared to wild type discs. The morphological eye defects caused 
by GMR-GAL4 are significantly enhanced when flies are raised at 29°C (presumably due 
to the higher activity ofGAL4 at this temperature). Taken together, this data suggests 
that GAL4 can have adverse effects on Drosophila development, especially at high 
expression levels. In addition, GAL4 appears to induce apoptosis even in the absence of 
any visible morphological defects. 
2.2.2 - Introduction 
The UAS/GAL4 ectopic expression system [1, 2] has become a widely used and 
extremely valuable tool for the overexpression oftransgenes in Drosophila melanogaster. 
This bipartite expression system utilizes the yeast transcription factor, GAL4, and its 
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target sequence, UAS (upstream activation sequence), to which GAL4 binds in order to 
activate gene transcription. GAL4 can be expressed in many different patterns by placing 
it under the control of various Drosophila promoter sequences. Since UAS promoter 
sequences (CGGAGTACTGTCCTCC) are not found in Drosophila (Berkeley Drosophila 
Genome Project, personal communication), it is assumed that GAL4 is inactive. This is 
very useful for the overexpression oftransgenes from a UAS promoter because GAL4 
will drive expression of the transgene while not otherwise affecting the cells. 
Many overexpression studies in Drosophila have been carried out in the 
developing eye using the glass multiple reporter (GMR)-GAL4 driver line [3]. Flybase 
currently lists 111 articles which have used the construct since its creation in 1996. The 
GMR promoter element causes high-level expression ofGal4 in the eye imaginal discs in 
cells posterior to the morphogenetic furrow. We have shown that GMR-GAL4 causes 
developmental defects and increased apoptosis in the eye, thus contradicting the notion 
that GAL4 is inactive in Drosophila. 
2.2.3- Materials and Methods 
Fly stocks and culture. 
GMR-GAL4 flies [3] were obtained from the Bloomington Stock Center and 11/ns 
was obtained from Dr. Howard Clipsheets. GMR-GAL4 homozygous females were 
crossed to w 1118 males and cultured on standard media at 25°C and 29°C. All fly stocks 
were transferred to a new vial every 2 days to avoid overcrowding. 
Analysis of adult eyes and imaginal discs. 
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For scanning electron microscopy, 2 day old females were desiccated overnight 
and coated in gold before photography with a Hitachi S570 scanning electron microscope 
(SEM). Acridine orange was used to visualize apoptotic cells in the eye imaginal discs, 
as described [4]. Third instar larvae were dissected in phosphate buffered saline (PBS) at 
pH 7.4 and imaginal discs were incubated for 5 minutes in 5 j.lg/mL acridine orange 
solution. Discs were rinsed in PBS and photographed immediately using Nikon eclipse 
E600 fluorescent microscope. 
2.2.4 - Results and Discussion 
The development of the Drosophila eye is a complex, yet relatively well 
understood process [5]. As a result, the eye is an excellent model for the study of genes 
involved in the control of developmental processes such as cell proliferation, 
differentiation, and apoptosis [6]. The UAS/GAL4 ectopic expression system has made it 
possible to overexpress genes specifically in the developing eye and test the effects of 
overexpression on eye development. 
The GMR-GAL4 driver is a commonly used construct for the missexpression of 
transgenes in the developing eye. It has been reported that GMR-GAL4 homozygotes 
have a rough eye phenotype that is visible under the dissecting microscope [3, 7-9]. Upon 
SEM analysis of flies with two copies ofthe GMR-GAL4 transgene raised at 25°C, it was 
revealed that the ommatidia! array was disrupted due to the presence of irregularly sized 
ommatidia (Fig. lC). Flies with one copy of the GMR-GAL4 transgene do not have an 
obvious phenotype at 25°C (Fig. lB) when compared to a control (Fig. lA), indicating 
140 
that the effects of GAL4 may be dependent upon the gene dosage. When flies were raised 
at 29°C the phenotypic effects of GMR-GAL4 were enhanced (Fig. 1 G-I). At this 
temperature two copies of the GMR-GAL4 transgene lead to the development of grossly 
deformed eyes (Fig. II) and one copy lead to slight abnormalities (Fig. 1H), whereas the 
control eyes still appeared normal (Fig. 1 G). The increased phenotypic severity seen at 
29°C may be due to the higher activity of GAL4 at this temperature [1 0]. Thus, we 
conclude that GMR-GAL4 causes developmental abnormalities in a dose- and 
temperature-sensitive manner. 
Acridine orange staining of the eye imaginal discs revealed high levels of 
apoptosis with two copies ofthe GMR-GAL4 transgene (Fig. 1 F & L) and intermediate 
levels with one copy (Fig. 1 E & K), when compared to controls (Fig. 1 D & J). 
Apoptotic cells are brightly fluorescent and are seen primarily where GAL4 is being 
expressed, in the region of the eye imaginal disc that is posterior to the morphogenetic 
furrow. Unlike the phenotype seen in the adult eye, there was no apparent difference in 
the levels ofapoptosis between flies cultured at 25°C and 29°C (Fig.1, compare D-F to J-
L). Thus, induction of apoptosis by GAL4 appears to be dose sensitive, but not 
temperature sensitive, and can occur in the absence of a visible adult phenotype. 
The induction of apoptosis by GMR-GAL4 may be indirect; i.e. apoptosis occurs 
as a result of developmental confusion caused by high levels of GAL4 and not through 
direct regulation of genes involved in apoptosis. For example, the Drosophila 
nucleoporin, members only, is required for nuclear import of GAL4 [ 11 ], thus, it is 
possible that high levels of GAL4 may block the normal shuttling of molecules in and out 
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25°C 
29°C 
Figure 1: t:xpn:ssJ 
element causes developmental defects and apoptosis in Drosop eye. Scanning electron 
microscopy reveals the phenotypic effect of GMR-GAL4 at 25 degrees celcius (A-C), and 29 degrees 
celcius (G-I). Acridine orange was used to stain apoptotic cells in the third instar eye imaginal discs 
from larvae raised at 25degrees celcius C (D-F) and 29 degrees celcius (J- L). Genotypes are W 1118 
(A, D, G, J), w; GMR-GAL4/+ (B, E, H, K), and w; GMR-GAL4/GMR-GAL4 (C, F, I, L). Arrows 
indicate the location of the morphogenetic furrow. 
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ofthe nucleus. However, the temperature sensitivity of the GMR-GAL4 rough eye 
phenotype may indicate that GAL4 is causing direct transcriptional activation of certain 
genes.lfthe phenotypic enhancement at 29°C is due to the innate preference ofGAL4 for 
this temperature, then GAL4 must be directly activating gene transcription in order to 
produce the phenotype. Alternatively, increased temperature may cause increased 
expression of GAL4 which could enhance the phenotype as well. 
Regardless of the mechanism by which GAL4 disrupts eye development, it is 
apparent that there is an effect, and that apoptosis is increased. Thus, it is imperative that 
experiments be well controlled and that new GAL4 constructs are well characterized to 
avoid misinterpretation of results. 
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Chapter 2.3 
Gal4-induced defects in Drosophila melanogaster are 
prevented by p35. 
This data has been submitted as part of a larger manuscript entitled: 
Haywood, A.F.M., Kramer, J.M., Sheppard, G.A., and B.E. Staveley, submitted. parkin 
suppresses Gal4-induced cell death. 
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2.3.1 -Introduction 
The UAS/Gal4 ectopic expression system is an impot1ant tool for the study of 
developmental processes in Drosophila melanogaster. In the previous chapter it was 
shown that Ga/4 causes a rough eye phenotype in adult flies when expressed at high 
levels during eye development. The rough eye phenotype is characterized by a loss of 
ommatidia! organization and is accompanied by a high level of apoptosis in the eye 
imaginal discs where Gal4 is expressed. Here it is shown that these phenotypes are 
essentially eliminated through co-expression ofthe caspase inhibitor,p35. This suggests 
that Gal4 has the capability to act as a toxic protein with the ability to activate the cellular 
apoptotic machinery. SEM and acridine orange analysis are done according to the same 
methods presented in chapter 2.2.3. 
2.3.2- Results and Discussion 
The GMR-Gal4 transgene expresses a high level ofGal4 in the eye imaginal discs 
in cells posterior to the morphogenetic furrow [5]. This expression causes obvious 
developmental defects in the adult eye (Figure IB) when compared to control flies 
(Figure lA) that do not contain the GMR-Gal4 transgene. Flies that have two copies of 
the GMR-Gal4 transgene also show a high level of apoptosis in the eye imaginal disc in 
the area posterior to the morphogenetic furrow (Figure IF) [3]. In contrast, control flies 
show some, but much less, apoptosis in the eye imaginal disc (Figure IE). This suggests 
that Gal4 induces apoptosis during development, which may cause the developmental 
defects seen in the adults. 
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Figure 1: Expression of p35 inhibits developmental defects and apoptosis in GMR-Ga/4 
homozygotes. Scanning electron microscopy (A-D) reveals the rough eye phenotype seen in 
GMR-Ga/4 homozygotes (B) as compared to a control (A). The rough eye phenotype is inhibited 
in the presence of one (C) or two (D) copies ofthe UAS-p35 transgene. Acridine orange staining 
(E-H) reveals apoptotic cells in the eye imaginal discs of third instar larvae. The amount of 
apoptosis is greater in G MR-Ga/4 homozygotes (F) than in control larvae (E). The presence of 
one (G) or two (H) copies of UAS-p3 5 essentially eliminates all apoptosis from the eye imaginal 
discs. Genotypes are w1n 8 (A, E), w;GMR-Ga/4/GMR-Ga/4 (B, F), w;GMR-Gal4/GMR-
Gal4;UAS-p35/TM6B (C, G), and w;GMR-Ga/4/GMR-Ga/4; UAS-p35/UAS-p35. 
To further examine this possibility, we co-expressed the caspase inhibitor, p35, 
along with Gal4 in the eye imaginal discs. Flies that have two copies of the GMR-Gal4 
transgene and either one (Figure lG) or two (Figure lH) copies of the UAS-p35 transgene 
show a nearly complete elimination of apoptosis during eye development. The 
disorganization of the ommatidia! array observed with GMR-Gal4 homozygotes (Figure 
lB) is reduced in the presence of one (Figure lC) and two (Figure lD) copies of UAS-
p35. The lack of complete suppression of the rough eye phenotype in the presence ofp35 
suggest that lack of apoptosis can also disrupt normal eye development, or that Gal4 
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effects eye development through mechanisms other than apoptosis. Neve11heless, these 
experiments suggests that Gal4 can cause apoptosis in the developing eye and that this 
can result in developmental defects. 
How does Gal4 cause apoptosis? High levels ofGal4 may cause transcription of 
genes involved in apoptosis. It seems unlikely that Gal4 causes transcription of the 
apoptotic machinery as there are no UAS sequences (CGGAGTACTGTCCTCC) found 
in the Drosophila melanogaster genome (Berkeley Drosophila Genome Project, personal 
communication). Alternatively, Gal4 may act as a toxic protein that can activate an 
apoptotic cascade. The inhibition of Gal4-mediated apoptosis by the caspase inhibitor 
p35 (Figure 1) suggests that the toxic effect of Gal4 leads to activation ofthe cellular 
apoptotic machinery. This may occur through a similar mechanism used by toxic 
proteins that cause apoptosis in neurodegenerative diseases [ 10, 11]. These mechanisms 
are not well understood, however, further analysis ofGal4-induced cell death may reveal 
additional mediators of toxic protein induced apoptosis. 
In summary, the UAS/Gal4 ectopic expression system can be an excellent tool, 
when used with the proper controls. However, caution should be used in the selection of 
promoters through which Gal4 is expressed, as high expression levels can cause caspase-
mediated cell death. 
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Chapter 3: Conclusions 
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This thesis describes the analysis of the FOXO family of transcription factors 
(Chapter 1) and the toxic effects of Gal4 expression (Chapter 2) in Drosophila 
melanogaster. In addition to establishing the existence of dFOXO, our analysis of the 
FOXO transcription factors has revealed their physiological importance in the adaptations 
ofDrosophila larvae to starvation. Our analysis ofGal4 overexpression has revealed that 
Gal4 can cause apoptosis in the developing eye. The effects of Gal4 expression are 
primarily a technical concern. However, further analysis ofGal4-induced apoptosis 
could provide insight into the general mechanisms controlling toxic protein-induced 
apoptosis (TPIA). 
Initial studies examining dFOXO loss of function in flies show that it is not 
required for normal development [1], thus raising questions regarding its evolutionary 
importance. Our studies suggest that dFOXO may provide an adaptive advantage in flies 
that is not observed under the optimal conditions experienced during laboratory culture, 
but may be essential for natural populations of Drosophila which are exposed to 
environmental challenges. Increased dFOXO activity allows larvae to survive nearly 
twice as long in the absence of food, and may contribute to the control of larval 
wandering (Chapter 1) [2, 3]. This increased survival time and wandering could 
significantly increase the chance for individuals to seek out food, and further their 
development to a reproductive age. Thus, the unnatural conditions of laboratory culture 
might mask the true importance of dFOXO in development and evolution. 
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Future Directions 
The studies described in this thesis have revealed several novel phenotypes 
resulting from genetic manipulation ofdFOXO [2, 3] and expression ofGal4 [4, 5]. 
These phenotypes provide a basis for future research that may increase our knowledge of 
human biology and provide a better understanding of human diseases, such as diabetes, 
cancer, and neurodegeneration. Indeed, Drosophila is an ideal organism in which to 
perform genetic screens aimed at identifying novel genes that participate in cellular 
processes and my contribute to disease symptoms observed in human ailments [6, 7]. 
Type 2 diabetes is characterised by defects in insulin secretion and/or insulin 
action [8]. These defects are influenced by environmental factors, such as diet, and 
genetic factors [8]. In mice, haploinsufficiency at the FOXOI locus suppresses diabetes, 
suggesting that aberrant regulation ofFOX01 is partially responsible for the diabetic 
phenotype [9-11]. Thus, the molecular mechanisms causing this disease could be further 
clarified by the dissection of genetic components involved in insulin signalling and 
regulation ofthe FOXO transcription factors. In Drosophila, loss of insulin producing 
cells leads to a diabetic phenotype [12] and loss of dFOXO leads to a great sensitivity to 
starvation in young larvae (Chapter 1.3) [3]. By searching for loss or gain of function 
mutations that suppress this phenotype, new physiologically relevant targets ofFOXO 
could be identified. Further analysis of these targets in Drosophila, mice, and humans, 
could provide insight into the molecular basis of diabetes. Thus, by truly understanding 
the mechanisms of the disease, we can begin to seek new methods of therapy. 
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Mutations in human FOXO homologues have been observed in patients with 
alveolar rhabdomyosarcoma [13, 14] and acute lymphocytic leukemia [15-18]. Cancer is 
a disease characterized by the loss of growth control in cells, thus, FOXO may play an 
important role in the suppression of cancer through its ability to induce cell cycle arrest 
[19]. Our experiments show that dFOXO can reduce growth when expressed in the 
developing eye of Drosophila (Chapter 2.2) [2]. Searching for mutations that suppress or 
enhance dFOXO-mediated growth in the eye could reveal physiological targets ofFOXO 
involved in the regulation of growth. It is possible that the analysis ofthese targets could 
provide information about the molecular basis of cancer, and provide novel targets for 
chemotherapy and/or gene therapy. 
Our analysis of Gal4 expression in the Drosophila eye suggests that Gal4 may act 
as a toxic protein to activate the cellular apoptotic machinery (Chapters 2.2 and 2.3) [ 4, 
5]. It has been suggested that toxic protein-induced apoptosis (TPIA) may contribute to 
neurodegenerative disorders, including Parkinson's disease, Huntington's disease, and 
Alzheimer's disease [20]. It is possible that a genetic screen for mutants that modify the 
Gal4-induced rough-eye phenotype could reveal important mediators ofTPIA. This 
would contribute to our knowledge ofthe molecular mechanisms responsible for TPIA, 
which may help reveal the physiological mediators of progressive neurodegeneration. 
Ultimately, these studies could lead to new therapeutic approaches to the treatment of 
neurodegenerative disorders. 
Drosophila is a powerful tool for the dissection of genetic pathways. Our analysis 
ofthe FOXO family of transcription factors and the toxic effects ofGal4 has revealed 
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several novel phenotypes [2-5], which could be used as a basis for further experiments 
aimed at identifYing novel genetic components involved in the liS signalling pathway and 
in TPIA. In conclusion, this could provide insight into the mechanisms of human 
diseases, and inspire new strategies for the treatment or prevention ofthese diseases. 
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